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Abstract
The ability of cells to export proteins is essential for numerous cellular functions.
Proteins for export are synthesised in the endoplasmic reticulum (ER) and move
through the Golgi complex to the trans-Golgi network (TGN), from where they are
shipped to various final destinations, including the plasma membrane (PM) (apical or
basolateral, in polarized cells), early and late endosomes, and secretory granules.
The membranous carriers involved in the trafficking step from the TGN
directly to the PM are much larger than vesicles, and are pleiomorphic rather than
vesicular. They also do not possess an external coat, as has been seen with other types
of carriers (e.g. clathrin, COPI and COPII vesicles). At present,the molecular
mechanisms of the formation of these large pleiomorphic carriers are completely
unknown.
I built up a thematic interactome to look at interactions between the many
players involved in TGN-to~PM trafficking, and I have added some newly discovered
interesting interactions through use of a two-hybrid matrix system. I thus focused my
attention on some key elementssuch as the Arfl and Arll interacting protein Arfaptin,
the TRAnsport frotein farticle (TRAPP) complex, protein kinase D (PKD) and C-
terminal binding proteinIBFA-ribosylated substrate (Ctbpl~SIBARS) since these were
rev~aled as being important nodes into this thematic interactome.
Arfaptin is a protein specifically recruited to the TGN through a BAR domain
which can interact with membranes, possibly bending them; thus, Arfaptin might be
relevant in the initial formation of carriers. We have discovered that PKD (a protein
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involved in fission) phosphorylates and displaces Arfaptin from the Golgi complex,
regulating its action in time, since the fission-mediated action ofPKD occurs later.
The fission activity of PKD can occur via Ctbp I ..S/BARS, which is already known to
be involved in membrane fission. Moreover, we have identified Ctbp I-S/BARS as a
PKD phosphorylation substrate ...
A possible role for the mammalian TRAPP complex in the exitofVSVG from
the Golgi to the PM (TGN-to-PM), comes from the study of interaction networks after
our two-hybrid screening. This has shown some links between TRAPP and other
relevant players, such as PKD and 14-3-31. Inyeast, TRAPPII has been characterized
as being relevant for post-Golgi exocytic trafficking. The TRAPPII complex
comprises TRAPPI (Bet5p, Trs20p, Bet3p, Trs23p, Trs31p, Trs33p, Trs85p) plus three
TRAPPn-specific components (Trs65p, Trsl20p, TrsI30p)~ Inyeast, as in mammals,
Bet3 is an essential component, since it can anchor the rest of the complex to Golgi ,
membranes. The removal ofBet3 both chronically, with specific siRNA and acutely,
with aicroinjection of specific antibodies, shows for the first time a role for TRAPP in
TGN-to-PM trafficking: Bet3 removal strongly delays the transport ofVSVG
specifically from the TGN to the PM, without affecting its ER-to-Golgi trafficking.
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Preface
One of the major characteristics that distinguishes living beings from inanimate things
is homeostasis, conceived as the ability to maintain an internal composition distinct
from the external, surrounding environment. Biological membranes provide the very
boundaries within which life can exist, separating the panoply of biochemical
reactions that define a living cell from the extracellular world. The plasma membrane
(PM) is present in all living organisms, as it was surely present as a necessary
condition for life in the first living organisms, which is started with the last universal
common ancestor (LUCA) that has been estimated to have lived some 3- 4 billion
years ago (Doolittle, 2000).
Compartmentalization is a mandatory condition for the maintenance of the
chemical and osmotic conditions inside the celf. Nevertheless, phospholipid bilayers
have many different functions other than compartmentalization, such as the selective
import of nutrients and catabolite discarding, along with signalling and membrane
trafficking events. These are the more evident functions of biological membranes.
Over millions of years of evolution, compartmentalization has become more elaborate,
since in eukaryotic cells, internal membranes have restricted specific cellular functions
into specific, physically delimited compartments, such as mitochondria and
chloroplasts, with the last inplants. The intracellular organelles have thus developed
inthe eukaryotic cell to allow specialized functions in specific areas of the cell.
Among all of the intracellular organelles, the Golgi complex is probably the
most dynamic and complex organelle, and the more fascinating from the
morphological point of view. However, the Golgi complex is also the most difficult to
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understand from the molecular and physiological point of view. One reason for this
complexity comes from the presence ofmany roads going to and coming from many
different compartments of the secretory pathway.
Membrane trafficking is an equilibrium between fluxes of:
• Membrane lipids and 'cargo' proteins that have to move to their final
destinations (PM, endosomes, vacuoles, lysosomes);
• Membrane lipids and resident enzymes that have to remain in their
'local' positions to maintain the subcompartment identity.
These two (in and out) fluxes both pass through the Golgi complex, which
occupies a central position in the physiology of membrane trafficking, maintaining
this equilibrium. Moreover, although membrane trafficking is extensive, it does not
compromise the identity of the compartments involved.
The exit from the Golgi requires the fine sorting of several pathways, which
occurs at the trans-Golgi network (TGN), among which the route starting from the
TGN and destined directly to reach and fuse with the PM (TGN-to-PM trafficking) is
the topic of this PhD project.
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1 Introduction
1.1 Background
1.1.1 The discovery of a complex organelle
In 1898) the Italian histologist Camillo Golgi firstly described the "apparato reticolare
interno", which literally means the 'internal reticular apparatus'. He used a
cytochemical staining procedure based on silver nitrate that was originally set up for
the study of the organization of the central nervous system. However, it was not until
the early 1950s, with the introduction of the electron microscope, that the existence of
the Golgi apparatus was fully accepted by the scientific community.
At that time) it became immediately clear how complex this organelle is. The
collective electron microscopy studies carried out over the following years established
that the Golgi complex consist of a morphologically heterogeneous set of membrane-
limited compartments that have common recognizable features) and they are
interposed between the endoplasmic reticulum (ER) and the PM. The constant and
most characteristic structural component of the Golgi apparatus is a stack of smooth-
surfaced cisternae (or saccules), which usually have a flattened, plate-like centre and
more dilated rims. Another constant characteristic of the Golgi complex is the absence
of ribosomes, which are instead confined in the rough endoplasmic reticulum (RER).
It is now clear that in addition to specific Golgi elements, the juxtanuclear
Golgi region is crowded with other cellular structures) such as coated vesicles,
lysosomes, and in many cases, centrioles with their associated microtubules.
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The current vision presents the Golgi complex as separated into distinct
components: the flattened cisternal saccules that are organised into stacks of cisternae
closely apposed to one another; the vesicular (or round profiles) tubular network; and
sometimes vacuolar profiles. Variations in the form, amount, and disposition of these
components occur in different cell types and in different functional states of the cell.
The cisternal profiles are divided into cis- medial- and trans-cisternae, starting from
the beginning of the secretory pathway, moving towards the exit fromthe Golgi. The
distal cisternae at both the cis and trans sides are less flattened and more tubulated,
and they are generally budded and have curved profiles (Fig. 1). Vesicular profiles and
tubular networks also characterize the extreme poles of these dynamic organelles.
Most plasma membrane and secretory proteins have one or more carbohydrate
chains, and one of the main functions of the Golgi is to add these sugarmoietiesto
these proteins. Some glycosylation reactions occur in the lumen of the ER, others in
the lumina of the cis, medial-, or trans-Golgi cisternae. Thus the presence of certain
carbohydrate residues on proteins provide useful markers for following their
movement from the ER and through the Golgi cisternae (e.g. endo-H resistance).
In addition, over the last decade, it has become clear that beyond its primary
biosynthetic, trafficking and sorting functions, the Golgi complex has an active role in
global cell processes that are not necessarily and directly linked to membrane
trafficking events, such as signalling, apoptosis and mitosis.
17
Figure 1. The Golgi complex
(A) Three-dimensional reconstruction from electron micrographs of the Golgi complex in a secretory animal
cell. The cis-face of the Golgi stack is that closest to the ER. (B) A thin-section electron micrograph
emphasizing the transitional zone between the ER and the Golgi complex in an animal cell. (C) An electron
micrograph of a Golgi complex in a plant cell (the green alga Chlamydomonas) seen in cross section. In plant
cells, the Golgi complex is generally more distinct and more clearly separated from other intracellular
membranes than in animal cells. (A, redrawn from A. Rambourg and Y. Clermont, Eur. 1. Cell BioI. 51: 189-
200, 1990; B, taken from Brij J. Gupta; C, taken from George Palade.)
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1.1.2 The TGN
The TGN is the most complex among the membrane trafficking compartments,
since it has the highest number of trafficking pathways that arrive and depart
(discussed further in chapter 1.1.6), making it the most complicated sorting station in
the cell (Fig. 2).
Novikoff and co-workers first described this compartment in 1964, and based
on electron microscopy evidence and on the observation that acid phosphatase activity
is often associated with this compartment, they postulated that these membranes
constitute a link between the Golgi, the ER, and lysosomes. Accordingly, they
introduced the acronym GERL as their designation (Novikoff and Novikoff, 1977). At
that time, it became immediately evident that the trans side of many (but not all) Golgi
stacks is often separated from the rest of the stack, and its characteristic morphology
has been described as varying from straight (rigid lamellae) to tubular and tortuous.
Later on, a more detailed description of this trans-Golgi network (TGN)
compartment was provided, indicating a system of tubules emanating from the trans-
most Golgi cisterna that provides the exit sites for the processed glycoproteins
(Griffiths and Simons, 1986).
Over the past few years, however, this model has been modified by
observations based on electron microscopy tomography and cryofixation (Mogelsvang
et al., 2004), which have demonstrated that the TGN can derive not only from the last
19
Figure 2. Three-dimensional tomographic reconstruction of the Golgi complex,
showing the eis-Golgi network (white) and the stack with the terminal three trans-
cisternae in purple, red and blue. The TGN (purple) appears as a tubular network that
emerges from the lateral part of one of the trans-cisternae, not necessarily the last
trans-cisterna (blue). Bar, 200 nm.
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trans cisterna, but also from the two adjacent trans cisternae, from which tubules
project into the space overlying the Golgi stacks. Importantly, only the last cisterna
and the tubules originating from it show clathrin-coated buds, indicating that
potentially only the last cisterna is involved in transport to endosomes, which relies on
clathrin-coated carriers (see below).
The current models of the Golgi complex do not usually incorporate the GERL
structure. Its role has remained controversial for many years (Griffiths and Simons,
1986), despite documentation of the existence of this Golgi-associated structure in
many morphological studies of different cell types. Then, the concept of the spatial
relationship between the ER and the TGN was refined, particularly with more recent
three-dimensional (3D) studies demonstrating that there are no continuities, whereby
the membranes of these two compartments can appose each other instead, at the so-
called ER -TGN contact sites, which are present in many different cell types (Levine
and Loewen, 2006).
Taking into consideration our present knowledge, the term TGN is biased, as
this organelle is composed of not only tubular networks, but also of disks, spheres and
vacuolar structures. Nevertheless, for the sake of clarity, this term remains, since the
TGN is still the most common term used to describe the Golgi exit sites among the
scientific community.
The function of the TGN as an intersecting of many transport pathways means
that it is the main sorting station. The TGN is important in this complicated situation,
to insure that every cargo goes towards its correct destination, and hence not along the
wrong pathway. The TGN functions as the main sorting station not only for newly
synthesized proteins and lipids to their appropriate cellular destinations, but also for
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the uptake of recycling proteins and lipids (Traub and Kornfeld, 1997; Bonifacino and
Rojas, 2006). In the TGN, both anterograde and retrograde cargoes are re-sorted to at
least two to six different destinations, depending on the cell type (Fig. 3). In many
cells proteins are delivered to basolateral or apical PM endosomes, and to lysosomes
or retrogradely to the Golgi complex (De Matteis and Luini, 2008). In regulated
secretory cells, such as pancreatic acinar cells, there is an additional pathway directed
through the storage and secretory granules.
The second main function of the TGN is participation in protein and lipid post-
translational and post synthetic modifications. The TGN compartment contains a
number of resident enzymes that are involved in the processing of the cargo
molecules, such as sialylation and fucosylation of N-linked and O-linked glycans and
sulphation of the glycosaminoglycans (GAGs). In addition, a number of proteins (e.g.
albumin) are processed in the TGN from their pro-forms to their mature forms, via the
cleavage of a pro-peptide, a process mediated by furin (Thomas, 2002).
1.1.3 Membrane trafficking
Generally speaking the term "membrane trafficking" describes the formation
and the movement of specific membrane-bound compartments, together with their
fluid-phase and protein contents (the "cargo") between and within intracellular
subcompartments, or organelles. Membrane trafficking comprises: the secretory,
endocytic and retrograde pathways.
In every eukaryotic cell, the huge number of proteins that pass thorough the
Golgi system to reach the external environment make the secretory pathway of
22
Figure 3 The endocytic and biosynthetic secretory pathways
In this "road map" of biosynthetic protein traffic, the endocytic and biosynthetic secretory
pathways (red) are illustrated. In addition, the retrieval pathways by which the backflow of
selected components is maintained are indicated.
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absolute importance, such as cargo proteins involved in extracellular matrix
construction/degradation, andreceptors, signalling hormones, and so on.
All secretory and membrane proteins contain a leader or a signal peptide that
can be segregated into the ER lumen or inserted into the ER membranes respectively.
Cargo proteins move along the exocytic pathway in a vectorial way, which fmally
drives them to the external environment, and this is by definition the secretory
pathway. Proteins that are not properly folded are retained in the ER by means of
interactions with molecular chaperones, such as Bip, calreticulin and calnexin, that
provide the correct "quality control" of proteins that exit the ER (Ellgaard and
Helenius,,2003). Once synthesized and properly folded into the ER, the secretory
proteins, membrane proteins of the PM or proteins that has to be retained in
endosomes or lysosomes, pass thorough the ER-Golgi intermediate compartment
(ERGIC), or vesicular-tubular clusters (VTCs), then they cross the eis-Golgi network
(CGN), the cis-, the medial- and the trans-Golgi cisternae and the trans Golgi network
(TGN), into which they are finally sorted and targeted to their final destination (Fig.
3). This last sorting step is remarkably complex.
The mechanisms by which proteins are synthesized or modified in one
intracellular compartment and then transported to another intracellular organelle
constitute one of the most challenging aspects for investigators in the field of
membrane trafficking. Each step in the secretory pathway is characterized by a
plethora of specific components that both regulate important processes, and provide
temporal and spatial resolution. As the anterograde transport of cargo progresses
through the secretory pathway, at the same time a large amount of membrane material
is transferred retrogradely from one cellular compartment to another, thus implying
24
the existence of a highly regulated compensatory system of membrane recycling that
maintains the identity of each organelle in terms of its lipid and protein composition
(De Matteis and Luini, 2008).
1.1.4 ER-to-Golgi transport
Protein folding in the ER is triggered by a class ofER-resident proteins known as the
chaperones. These proteins mediate both the folding of newly synthesized proteins,
and the retention of misfolded proteins within the lumen of the ER. Among the
chaperones, those that have been better characterised to date are the lectins calnexin
and calreticulin, and other enzymes, such as BIP and protein disulphide isomerase
(PDI) (Ellgaard and Helenius, 2003).
Once properly folded, newly synthesized proteins are sorted from the ER-
resident proteins in the specialised zones known as ER exit sites, which are scattered
over the surface of the ER. Here, the Ras-related small G protein Sarl begins the
process of the assembly of cytosolic COPII components for the formation of a
complex sitting on the bilayer in a 'cage' form which promotes membrane budding
and the subsequent formation of a transport carrier (Schekman and Orci, 1996). The
COPII assembly on the membranes at the ER exit sites start with the Secl2-mediated
nucleotide exchange of GTP (in place of GDP) on Sarl , This exchange is potentially
triggered by cargo molecules or putative cargo receptors. The Sec23/24 and Sec 13/31
heterodimers are then assembled on the cytoplasmic leaflet of the activated ER
membrane, to form the COPII-coated bud (Fig. 4). This bud is generally believed to
transform-into a 50-nm vesicle, although it may not immediately sever, potentially
allowing the formation of a tubule that could cluster with other adjacent COPII-
derived tubules. ER exit sites observed at the electron microscope usually contain
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multiple budding profiles, possibly representing budding vesicles that subsequently
fuse locally to form pleiomorphic pre-Golgi transport intermediates (Stinchcombe et
al., 1995). An alternative possibility is that the budding profiles represent ER exit sites
that transform directly into pre-Golgi intermediates without the need for small 50-nm
vesicle intermediates (Mironov et al., 2003), as happens in the classical view ofER-
to-Golgi transport. What is clear from the molecular point of view is that the Sar 1-
COPII system is necessary to allow transport from the ER to the Golgi, since mutants
of COP II components or Sarl result in a block in protein exit from the ER (Kaiser and
Schekman, 1990; Barlowe et al., 1993).
1.1.5 Golgi-to-ER retrograde transport
Resident ER proteins, such as the chaperones mentioned above, can 'escape' from the
ER along with anterograde cargoes. Then from their workplace (the ER) they 'fall'
into VTC or Golgi compartments. Thus, to maintain the compartmental identity of
both ER and Golgi these proteins need to be retrieved back from the Golgi via a
transport system that is distinct from the COPII system.
COPI is an heptameric (a.-,~-,W-, Y-, 8-, E-, l;-COP) cytosolic protein
complex that exists in a preassembled form in the cytosol (Bonifacino and Lippincott-
Schwartz, 2003). In conjunction with the Ras-like GTP-binding protein Arfl, it
assembles onto Golgi membranes to form an electron-dense coat that facilitates
membrane budding (and probably also fission) of transport intermediates (Pepperkok
et al., 1993) (Fig. 4). Although initially the COPI system was believed to mediate
anterograde cargo transport (pepperkok et al., 1993), these COPI vesicles are not
enriched with anterograde cargoes. One possible explanation for the COPI-
anterograde hypothesis could be that indirect effects on anterograde transport can
26
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Figure 4. COPI coats and clathrin-adaptor coats
(a) The 'classical' AP2 clathrin adaptor with its four subunits forms a complex that links
cargo recruitment to clathrin. Clathrin is a trimer and each terminal domain is represented
as being bound to a P2 adaptin appendage and hinge domain. (b) The COPI subunits (c)
The COP II subcomplexes, Sec23/24 and Sec13/31. (a,b,c) Inset: EM image of relevant
coated-vesicle budding. Scale bar, 100nm (d) Alternative clathrin adaptors GGAs and Hrs.
(from McMahon et al. 2004)
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occur due to disequilibrium between anterograde and retrograde transport, which are
mutually dependent.
At present, one of the most accepted roles for the COPI machinery is to
mediate the budding of retrograde vesicles, which would recycle proteins back from
the Golgi complex to the ER, or from late Golgi compartments to early Golgi
compartments (Pelham, 1994). The COPI subunits can bind dilysine residues in the
motifKKXX, which is believed to function as an ER-retrieval sequence on proteins.
Moreover, proteins that have mutations to these sequences are delivered to the cell
surface (Letourneur et al., 1994).This KKXX motif is present in the KDEL receptor, a
recycling protein that is involved in the retrieval ofER-resident proteins containing
the KDEL signal sequence, such as the chaperones (Griffiths et al., 1994).
1.1.6 Many pathways to and from the TGN .
The role of the TGN as a point of intersection of many transport pathways
means that it is the main sorting station. The TGN is important to ensure that cargoes
go towards their correct destinations, and not along the wrong pathways. Indeed, the
TGN functions as the main sorting station not only for newly synthesized proteins and
lipids, but also for recycling proteins and lipids (Traub and Kornfeld, 1997). In the
TGN, both anterograde and retrograde cargoes are sorted to at least two to six different
destinations, depending on the cell type. In ordinary cells, proteins are delivered to the
basolateral or apical PM, or to endosomes, or lysosomes, or retrogradely to the Golgi
complex (De Matteis and Luini, 2008). The TGN also receives proteins and lipids
moving from the PM towards the ER, such as with the bacterial toxins, like the Shiga
toxin family (Sannerud et al., 2003). In regulated secretory cells there is an additional
pathway directed to storage or secretory granules (Tooze, 1998) (Fig. 6).
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Some of these cargo carriers that bud and are released from the TGN are
clathrin-dependent. The formation of these clathrin-coated carriers is triggered by Arfl
which, via its GTP/GDP cycle promotes the recruitment and activation of adaptor
proteins, such as the APs (API, AP3, AP4) or the 'atypical' adaptors Golgi-localized,
y-ear-containing Arf-binding proteins (GGAs) (Fig 4). APs (the acronym originally
meant 'assembly polypeptides' although conveniently it also stands for 'adaptor
protein') then mediate clathrin recruitment and cargo segregation (Robinson, 2004).
Clathrin-coated carriers mediate the formation of vesicles containing the mannose-6-
phosphate receptor (M6PR), which is destined to the late endosomes (LEs), and the
formation of the secretory granules destined to the external surface in a regulated
fashion.
1.2 TGN-to-PM transport
1.2.1 General view
The transport of membrane-bound or secreted proteins from the TGN directly to the
external surface is generally considered as a constitutive pathway. This transport
occurs in all known cell types and is divided into apical (AP), e.g. the GPI-anchored
proteins, p75, and HA cargoes, and basolateral (BL) transport, e.g. the vesicular
stomatitis virus G protein (VSVG) and LDL receptor cargo transport in epithelial (thus
polarized) cells. For many years MDCK cells have been the model for targeted
delivery since they have a clear epithelial polarity.
Apical and basolateral membrane domains can be recognized in all epithelial
cells; indeed, they can also be recognized (with less confidence) in non-epithelial cells
that have specialization of different PM domains, such as hepatocytes, retinal pigment
epithelium cells, retinal, rod photoreceptors, hippocampal neurons and osteoclasts.
These cells thus show transport towards distinct domains of the plasma membrane
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(Keller and Simons, 1997) (Fig 5). In some cases, the polarization of secretory cargoes
can depend on the functional state of the cell, as in the case of human fibroblasts:
when they are 'resting', the delivery of different cargoes occurs randomly towards all
of the PM, while when they are in a functional state of movement instead, different
cargoes appear to be segregated towards different PM domains, such as the leading
edge of the cell.
Until a few years ago, it was believed that all intracellular carriers were small
coat (e.g. clathrin, COPII and COPI)-derived vesicles, but it is now clear that the bulk
of the traffic is carried by large pleiomorphic tubular-saccular intermediates. This is
the case for the transport between the ER and the Golgi complex via VTCs (as
mentioned above), and also for transport between the TGN and the PM, which is the
topic of this thesis.
Although VTCs have a pleiomorphic structure that is to some extent
comparable to the carriers that mediate TGN-to-PM transport, they also have COP I
and COPII present on some part of their structure; TGN-to-PM carriers do not. Indeed,
the biggest difference seen for TGN':to-PM transport, as compared to the above-
mentioned trafficking routes, is the absence of clathrin or another type of coat, at least
revelable by electron microscopy as an electrondense coat, as is the case for COPI-,
COPII- and clathrin-coated structures (polishchuk et al., 2003).
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Figure 5. Apical and basolateral pathways in polarized and non-polarized cells
Membranes equivalent to the apical and basolateral surfaces of (A) MDCK cells are depicted in red and dark
blue, respectively. (B) While in a resting fibroblast apical and basolateral pathways reach the cell surface
randomly, (C) a migrating fibroblast uses the basolateral route to deliver newly synthesized proteins to the
leading edge. (D) Hepatocytes contain at least two pathways to the basolateral surface. They, however, do
not have a direct apical pathway,but instead use a transcytotic route. As indicated by the question mark, it is
not known whether apical proteins use a raft-dependent mechanism to reach the basolateral surface in
hepatocytes. (E) Retinal pigment epithelium cells use a direct as well as an indirect pathway for apical
delivery. (F) In hippocampal neurons the axon and somatodendritic surfaces are equivalent to the apical and
basolateral domains of MDCK cells, respectively.
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Figure 6. The trans-Golgi network (TGN) sorts newly synthesized proteins
The trans-Golgi network (TGN) sorts newly synthesized proteins that arrive from earlier Golgi
compartments (I) towards different destinations (1-6).1t also receives input from the endocytic pathway
(II-IV) and sends back components to the earlier Golgi compartments (7). The exit routes from the TGN
include those towards the apical plasma membrane (1), the basolateral plasma membrane (2), recycling
endosomes (3), early endosomes (4), late endosomes (5) and specialized compartments such as secretory
granules (6) in secretory cells. Secretory proteins can also use a transendosomal pathway through
recycling endosomes to reach the basolateral (3, 3a) or apical surfaces (3, 3b). Golgi-resident proteins
recycle back to the Golgi stack (7), as secretion consumes the last trans-Golgi cisternae. The endoplasmic
reticulum makes close contact with the last two trans-Golgi cisternae (black boxes), through which lipid
exchange can occur between these two organelles. Picture taken by (De Matteis and Luini Nat Rev Mol
Cell BioI2008).
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The major characterisation of these so called 'pleiomorphic' carriers is due to
morphological studies carried out over the past few years, which gave them the name
of Golgi-to-plasma membrane carriers (GPCs) (Luini et al., 2008).
GPCs are more easily seen after the release of a 20°C temperature block
(allowing secretory proteins to reach the last compartment of the Golgi complex, but
not to leave it, resulting in accumulation of cargo in the Golgi). After the temperature
shift to 32°C the transport toward the PM occurs in the form of large (sometimes as
much as half the length of a cisterna), pleiomorphic/tubular, sometimes
fenestrated/anastomosed, membrane carriers. These bud, elongate, and then detach en
bloc from the TGN, and finally follow microtubular tracks until they fuse with the PM
(Polishchuk et al., 2003).
The "lifecycle" of a GPC consists of four distinct stages: (i) the formation of
TGN tubular export domains, where different cargoes are segregated from each other
and from the Golgi enzymes; (ii) the docking of these tubular domains onto molecular
motors and their extrusion towards the cell periphery along microtubules; (iii) the
fission of the forming GPC from the donor membrane; and finally (iv) the delivery of
the newly formed GPC to the plasma membrane (Fig. 7).
The first step (formation) includes the segregation of the cargo proteins from
the Golgi-resident enzymes. These export domains usually contain TGN markers, such
as TGN46; Le. they are part of the TGN (Polishchuket al., 2003). As described above,
the TGN derives not only from the last trans cisterna, but also from the three trans-
most cisternae, from were tubules emanate into the trans space of the Golgi stacks.
Remarkably, only the trans-most cisterna has clathrin-coated buds. Thus it is likely,
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although yet to be formally demonstrated, that the carriers emanating from the
clathrin-free cisternae are all contributing to the formation of Gl'Cs that are
constitutively directed to the PM.
The second step (extrusion) apparently requires the pulling force of molecular
motors, such as kinesin (see below). This pulling force is applied to the TGN
membranes, and it is important to facilitate the extension of GPe precursors from the
Golgi body, and later for the fission step of the GPe (see below) (Kreitzer et al., 2000;
Polishchuk et al., 2003). In cell-free systems, the addition ofkinesin to Golgi
membranes (and even to liposomes) together with microtubules induces the formation
of tubule-like membranes that are similar to GPe precursors (Roux et al., 2002), while
a block of kinesin function by microinjection of an inhibitory antibody (Kreitzer et al.,
2000) or expression of the headless kinesin mutant (Nakata and Hirokawa, 2003)
prevents GPe formation from the Golgi complex. Kinesin has been seen to be
associated with the tip of the GPe precursors, although it can also attach to other
points along the GPe precursor membrane (Polishchuk et al., 2003).
Microtubular motors can have critical roles also in the third step (fission): the
movement of kinesins along microtubules can create tension within a GPe precursor
that facilitates the fission process. Indeed, based on in-vitro data, membranes under
tension have recently been proposed to have an important role in fission (Roux et al.,
2Q06). In vivo, the stop-and-go characteristic movement of Gl'Cs directed to the PM
(Polishchuk et al., 2003) might be due to a fission event that is concomitant to a pause
in the movement, which reasonably corresponds to the time required for a tubular
membrane to stretch and break under tension. The movement can then continue to
bring the smaller, severed membrane carriers towards the PM.
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What has been seen from this time-step analysis of the constitutive TGN-to-
PM transport is indeed the important role of morphological knowledge in the
understanding of such a complex process.
The morphology of the TGN is very dynamic and depends also on its secretory
status. When exit from the TGN is blocked by a lowering of the temperature to 20°C
in the presence of abundant cargo, the volume and surface area of the TGN increase
greatly (Griffiths et al., 1989); while in the absence of cargo; a 20°C block results in
all three of the trans-most cisternae producing bulging exit domains (Ladinsky et.al.,
2002). At physiological temperatures, three-dimensional (3D) analyses of the Golgi
stacks have revealed well developed, tubular-reticular, TGN-like membranes at the
trans side of the Golgi complex in actively secreting cells, while the TGN is nearly
absent in quiescent cells (Trucco et al., 2004).
From these observations, a model of the TGN emerges by which this organelle
consists essentially of a dynamic assembly of tubular export domains that form on
arrival of cargo and that are then consumed as export carriers. In this context, the
questions that arise are: How is the segregation of cargo within the distinct tubular
domains of the TON achieved? How are the different tubular domains established?
How are they converted into export carriers?
Below, I will describe the underlying mechanisms separately, although they
might in fact operate concomitantly and in an integrated fashion. In the 'molecular
players' section, I will list the individual entities, along with their known molecular
roles, and in the 'molecular machineries' section, I will attempt to group them into
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(relatively arbitrary) separate functional modules, based on the current models in the
literature.
1.2.2 Molecular players
The transport of the G protein of vesicular stomatitis virus (VSVG) in its thermo-
sensitive (ts) version is used as a reliable and potent marker of transport in the
secretory pathway, as it is synchronizable by temperature blocks: at 40° C, VSVG is
retained in the ER because the temperature sensitivity causes a folding problem, then
at 32° C, VSVG can assume its correct conformation, and it can thus leave the ER.
Another way to syncronize VSVG (as with many other molecules) is with a 20° C
temperature block, which allows VSVG to reach the Golgi complex, but blocks its exit
from the TGN. This is not due to a folding problem, but it depends on a still
unclarified mechanism. Here, I will describe the molecular players that are responsible
for TGN-to-PM traffic ofVSVG, grouping them into functional·classes.
Signalling proteins are involved in a series of signalling pathways, which are
apparently unrelated to trafficking. In futurework, signalling proteins and their
pathways can put in relationship the external stimuli and the regulation of Golgi
functions.
The ~1y21 ~3y2 subunits of the heterotrimeric G-proteins can trigger the
activation ofPKC11, which in tum activates protein kinase D (PKD), promoting the
fission of PM-directed carriers containing VSVG (Liljedahl et al., 2001; Yeaman et
al., 2004; Diaz Anel and Malhotra, 2005). PKD is also responsible for a series of
cellular processes, as it is a signalling protein that triggers cell survival, cancer,
invasiveness and immune responses (Wang, 2006).
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Src kinase is important in an endomembrane signalling circuit that is triggered
by ER-to- Golgi trafficking, allowing the progression ofVSVG out of the Golgi
(Pulvirenti et al., 2008). Src might thus provide regulation of the homeostasis between
the arrival and departure membranes and cargoes.
Small G proteins and their related factors are fundamental regulators of
membrane trafficking. The Arfl protein acts in the multiple regulation of several
pathways in membrane trafficking (Donaldson et al., 2005) as briefly elucidated in the
previous sections. In the TGN-to-PM trafficking ofVSVG Arfl acts via the
recruitment and activation ofPI4KIII~ on the Golgi complex, thus triggering the
production of phosphatidylinositol 4-phosphate (PtdIns4P), and thus acting on the
local lipid composition, generating distinct TGN microdomains (De Matteis and Godi,
2004). Many Arfl regulators and effectors arepresent at the TGN, including the
brefeldin A (BFA)-sensitive GDP/GTP exchange factors (GEFs) BIGI and BIG2
(Gillingham and Munro, 2007), and the GTPase-acti.vating protein (GAP) ARAPl,
which is enriched at the TGN (DeMatteis laboratory, unpublished observation).
The small GTPase Cdc42 is a regulator of actin polymerization that has been
characterized as having important functions in signalling and cytoskeletal
reorganization. Cdc42 binds to the Golgi complex in an Arf-dependent fashion
(Erickson et al., 1996; Egea et al., 2006), and it regulates the dynamics of a local pool
of short actin filaments at the Golgi complex (Cohen et al., 2001; Musch et al., 2001).
Through this interaction Cdc42 might control the polarization of trafficking markers
(Musch et al., 2001). LIMKI kinase can also regulate actin dynamics via cofilin at the
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growth cones in neuronal cells, which receive a substantial transport of post-Golgi
material for the developing neurons (peter et al., 2004; Rosso et al., 2004).
The Arf-like protein Arll is exclusively located at the TGN, and, when in the
active (GTP) form, its well characterized action consists of the recruitment of several
GRIP-domain-containing proteins (Lu and Hong, 2003; Lu et al., 2006). The GRIP
domain is a coiled-coil structural feature of still obscure function that interacts
specifically with TGN membranes also through homo-dimerization (Lu et al., 2006).
The GRIP-domain-containing proteins that are specifically recruited to the TGN are
GCCI85, GCC88, Golgin97 and p230/245 (Munro, 2005).
Recently a link between GRIP-containing proteins and Rab proteins has been
shown (Burguete et al., 2008).
Over 60 members of the Rab family of small G-proteins have been identified,
among which there are Rab 11, Rab6 and Rab8 that are interesting for post-Golgi
trafficking. In particular, Rab6 is present on TGN-derived carriers and regulates
exocytosis by enhancing the processive kinesin-dependent motion of secretory
vesicles (Grigoriev et al., 2001). Recently, Rab6 has been shown to interact with
GCCI85, a GRIP-domain-containing protein that is also an interactor of Arl1, and this
interaction occurs in a non-exclusive way. Moreover the Rab6-GCC185 interaction is
necessary for TGN recruitment of GCCI85-Arl1 (Burguete et al., 2008). Rab8
controls AP1B-dependent trafficking ofbasolateral carriers (Kroschewski et al., 1999;
Musch et al., 2001; Ang et al., 2003), and recent data from the Rab8 knockout mouse
also indicate its involvement in apical trafficking in intestinal cells (Sato et al., 2007).
Regulation of carrier motility is the candidate sphere of action for Rab8, considering
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that it associates with optineurin, which binds myosin VI and FIP2, the latter being
responsible for the association with actin through hungtintin (Hattula and Peranen,
2000; Sahlender et al., 2005; Au et al., 2007). Rab11a is localized at the TGN, on
recycling endosomes and in specialized membrane compartments in secretory cells
(Goldenring et al., 1996; Ullrich et al., 1996). It has also been implicated in
basolateral trafficking (Chen et al., 1998; Lock and Stow, 2005).
Arfaptin is an effector of both Arfl and ArU, and it interacts with the GTP-
bound forms of both proteins. Arfaptin1 is involved in the transport of matrix-
degradation factors (Ho et al., 2003). Arfaptins (1 and 2) are specifically localized at
the TGN (DeMatteis laboratory, unpublished observations) and they have a BAR
domain, which has been structurally determined to be a membrane-curvature sensor
(Peter et al., 2004).
Phospholipid metabolism proteins, can directly modify the phospholipids,
e.g. phosphatidylinositol 4-kinases (PI4K) and phosphatases, or they can transfer
specific lipid species from one intracellular compartment to another, where the
enzymes for their metabolism are located. Activation of ARF can trigger the
generation of distinct TGN microdomains through an action on the local lipid
composition, since it stimulates the production of PtdIns4P, recruiting and activating
PI4KIII~ (see above). As with the phosphoinositides in general, PtdIns4P acts as a
gathering point fOTthe recruitment of a specific set of cytosolic proteins that contribute
to the local specialization of the TGN membrane. Indeed, this Arfl-PtdIns4P pairing
can be considered as a marker for TGN domains, as is the Rab5-PtdIns3P pairing for
early endosomes (Shin and Nakayama, 2004). Neuronal calcium sensor (NCS)-
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1IFrequenin interacts with PI4K and positively regulates its activity, although NCS-
1IFrequenin also inhibits the Arf-mediated activation ofPI4K (Haynes et al., 2005).
The lipid-transfer proteins are another important class of proteins which
include ceramide transfer protein (CERT), phosphatidylinositol-four-phosphate
adaptor protein 2 (FAPP2) and oxysterol-binding protein1 (OSBP1) (Holthuis and
Levine, 2005). FAPP has been visualized on tubular carrier precursors (Godi et al.,
2004) and FAPP2 has been proposed to transfer glucosylceramide from the Golgi
complex into the TGN (D'Angelo et al., 2007). Here, tubulation could result from the
selective transfer of lipids into the cytosolic TGN membrane leaflet, creating
transmembrane area asymmetry and hence curvature (Zimmerberg and Kozlov, 2006).
The other transfer proteins CERT and OSBP1 might have important roles too, through
their insertion of ceramide and cholesterol, respectively, into the TGN membranes
(Levine and Loewen, 2006). This would also facilitate membrane curvature (Shemesh
et al., 2003; Zimmerberg and Kozlov, 2006).
The lipid-metabolizing enzyme phospholipase D1 (PLD1), which can be
activated by Arfl (Roth et al., 1999) (and also by hormones and growth factors),
converts the phospholipid phosphatidylcholine (PC) into phosphatidic acid (PA). Its
product is a structural component of membranes that promotes membrane bending
and/or recruits several proteins involved in membrane trafficking (Manifava et al.,
2Q01;Ktistakis et al., 2003). Nir2 is a PI-transfer protein that is involved in TGN-to-
PM trafficking, and its depletion results in a reduction of diacylglycerol (DAG) level
in the Golgi complex (Litvak et al., 2005).
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Proteins involved in several other functions, such as scaffolds, tethering
complexes and transmembrane proteins localized at TGN with unknown functions,
might also be relevant in the understanding ofTGN-to-PM transport.14-3-3 is a
scaffolding protein that interacts with PI4KlII~, in its S294 phosphorylated form
following the kinase activity ofPKD (Hausser et al., 2005). The action of 14-3-3 is
specifically to protect the S294 specific phospho-site from de-phosphorylation
(Hausser et al., 2006). Moreover, once 14-3-3y isoforms are knocked-down by siRNA,
the VSVG transport from TGN to plasma membrane is impaired (Luini laboratory,
unpublished observations). C-terminal binding protein/Brefeldin A-ribosylated
substrate (CtBP1-SIBARS) is a multifunctional protein that has key roles both as a
transcription co-repressor in development and oncogenesis (Chinnadurai, 2002), and
as a promoter of Golgi membrane fission (Weigert et al., 1999). More recently BARS
has been characterized as exerting its fissioning activity on VSVG-containing carriers
in TGN-to-PM trafficking (Bonazzi et al., 20(5).
The TRAPP complex, and especially its most conserved subunit Bet3, has been
characterized in mammals as being important for the homotypic-mediated fusion of
COP II vesicles, and it is thus necessary for the progression ofVSVG from the ER to
the Golgi complex, accordingto the (although debated) homotypic-fusion model of
transport (Yu et al., 2006). There are many pieces of evidence implicating TRAPPII
(TRAPPI plus Trs65p, Trs120p, Trsl30p) in late-Golgi pathways in yeast, such as the
synthetic lethality of Trs65p with the phosphoinositide 4-Kinase Pik 1P (Sciorra et al.,
2005). Moreover, when Trs130p is knocked-out, invertase accumulates inside the
Golgi (Cai et al., 2005). TRAPPI is aGEF for Yptlp and TRAPPII is a GEF for
Ypt31/32p. Moreover, Trs65 is responsible for the GEF-specificity shift from Yptl pto
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Ypt31132p, and this last Rab protein homologue is involved in post-Golgi traffic in
yeast (Liang et al., 2007).
TGN46 is a single-pass membrane protein, and it is probably the most well
known specific marker of the TGN compartment; however, its function at the present
time is unknown.
Clathrin (although never found on GPCs) has been recognized recently as
being important for TGN-to-PM trafficking ofbasolateral cargo, even when it is
blocked in an acute way (Deborde et al., 2008). At the present time, it is impossible to
understand the functional role of c1athrin in transport of GPCs carriers that are
completely devoid of this (and any other) coat.
1.2.3 Molecular machineries
In this section I will group the players described above into arbitrary and
separated functional modules, based on the current models intothe literature. I will
refer to these functional modules as: tubulation, fission and transport modules and
each will be associated with the corresponding temporal steps described above (Fig 7).
The tubulation module (Fig.7a) starts its action with the GEFs BIG 1and
BIG2, which activate Arfl, exchanging its GDP for GTP and allowing it to insert its
hydrophobic moiety into the TGN membranes in a specific way. Thus BIGl, 2 act in
the opposite way to GBF-l (another Arfl GEF), which instead restricts the activity of
Arfl on the intermediate compartment and eis-Golgi. Nothing else is known about the
roles of BIG 1,2, and the way they are recruited to their sites of action is completely
unknown. Active Arfl recruits PI4KIII~, which in turn enhances the local production
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ofPtdIns4P, and PtdIns4P recruits FAPP. FAPP is also directly Arfl dependent, and
at the TGN they promote the tubulation ofVSVG-containing carriers (GPCs, see
above), and its action can be directly related to the ability to maintain a local PtdIns4P
population on tubulation sites via the PH domain (Godi et al., 2004). The action of
Arfl on tubulation appear thus to be indirect; however the tubulation can be promoted
by the direct Arfl interactors Arfaptinl,2, which have a BAR domain structurally
determined as a membrane-curvature promoting agent (Peter et al., 2004). Moreover,
Arfaptinl,2 also interact with active Arll, which in contrast to Arfl, is specifically
located at the TGN (Burd et al., 2004). The action of Arfaptinl,2 on tubule formation
has been verified in vitro, via a liposomal tubulation assay (peter et al., 2004).
Theftssion module (Fig. 7b) starts with G~y, which activate PKCll. Both
PKCll and DAG activate PKD, and thus Nir2 can participate in the process activating
the CDP-choline pathway, which in turn leads' to increased DAG production (Luini et
al., 2005). The kinase activity ofPKD is necessary for the fission ofVSVG-containing
GPCs (Liljedahl et al., 2001). Active PKD then activates PI4KIII~ via
phosphorylation at serine 294, and this phosphorylation is relevant, but not strictly
necessary, for fission (Hausser et al., 2005).
PI4KIII~ is probably not the only PKD substrate that is required for fission
activity, since the PI4KIII~ S294A mutant delays VSVG exit by only half the rate
compared to a PKD kinase-dead (KD) mutant (Hausser et al., 2005). A constitutively
active (CA) PKD mutant fragments the Golgi as a consequence of the hyperactivation
of the fissioning activity (Bossard et al., 2007). This indicates the need for a regulating
feedback that allows the fission machinery to act in the correct way in space and time,
to produce the GPCs, according to details described above (fission can occur between
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hot spots in which the VSVG cargo is more concentrated; see chapter 1.2.1)
(polishchuk et al., 2003).
CERT provides ceramide to the TGN compartment, then Golgi-localized
sphingomyelin (SM) synthase 1 uses ceramide and phosphatidylcholine (PC) to
generate SM and DAG (Perry and Ridgway, 2005). DAG isa prerequisite for PKD
recruitment and activation. The other side of the story is that CERT is inactivated by
PKD phosphorylation, providing a lower amount of ceramide; consequently, it
provides a lower amount ofDAG to the TGN compartment. This mechanism was
recently proposed in the regulation ofPKD-mediated transport (Fugmann et al., 2007).
CtBP I-SIBARS has been characterized as being important in the transport of
VSVG from the TON to the basolateral PM in COS7, HeLa and MDCK cells, and its
role in the process has focused on membrane fission. This arises from the observations
that VSVG-containing tubules are not impaired in their formation from the TGN
membranes, but they are not able to detach, when specific siRNA were used and also
using the dominant negative deletion mutant nucleotide-binding domain (NBD) of
BARS and dominant negative point mutant D355 (Bonazzi et al., 2005). However,
neither the regulation of BARS, nor the fine molecular mechanism BARS exerts onto
the GPCs to drive the fission activity, are clear to date.
Another player in fission is dynamin, a protein that is well known as having a
key role in fission at several trafficking stages (Orth and McNiven, 2003). Dynamin is
present in the Golgi complex (McNiven et al., 2000) and is required for the export of
p75 from the Golgi in polarized cells. BARS and dynamin act on different cargoes and
pathways (Bonazzi et al., 2005).
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The transport module (Fig. 7) (which is probably the least clear) is mediated
by cytoskeletal motors that drive moving forces in transporting cargo along
cytoskeletal tracks, along with tethering factors that assure specificity of the final
cargo delivery. The elongation of carrier precursors from the TGN and their
translocation through the cytosol occurs along microtubules (Polishchuk et al., 2003)
by virtue of microtubule-based motors (usually kinesins), and this happens in nearly
all animal species (Jaulin et al., 2007). In mammalian cells, motors interact with
transport carriers in a remarkably, but not completely, selective fashion.
Kinesin heavy chain-5B (KIF5B) is a well studied molecular motor, which
mediates apical trafficking ofp75 in MDCK cells (Jaulin et al., 2007). However, these
motors can also show a degree of promiscuity, as KIFIB has also been implicated in
Rab6-dependent trafficking ofVSVG in a non-polarized cell line (Grigoriev et al.,
2007).
The TRAPPII complex is considered to be a tethering factor, and at least in
yeast its role as a GEF for Ypt31/32p has been established (Liang et al., 2007). The
functional homologue ofYptJ1/32p in mammals can be Rabll, Rab6, and Rab8,
which are involved in BL transport (see above: molecular players/small G-proteins).
The TRAPP complex can be important for post-Golgi trafficking, at least into this last
step of membrane targeting of GPCs.
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2 Aim of the project
The aim of my PhD project consists first in the bioinformatic collection of
interactions between thematically chosen players ofTGN-to-PM trafficking in
mammals, using web-based databases, such as STRING (http://string.embl.de//).
Moreover, I have collected not only proteins that are functionally relevant in the
process, but I have collected also proteins localizing specifically at the TGN, even if
their function is still not clear, e.g. ArU, Arfaptin and TGN46. This provides the hope
of better defining the puzzling molecular machineries that have roles in the different
temporal steps mentioned above, considering also the possibility that these roles can
be overlapping. The need to better define these molecular machineries comes from the
comparison between the high level of organization of the clathrin, COPI and COPII
machineries on one side, and the lack of knowledge about consequentiality, temporal
organization and regulation of the TGN-to-PM routes at the molecular level on the
other side (Fig. 7). The concept is thus to look for new protein-protein interactions,
with the aim of better defining the molecular aspect of the problem. Then the goal is
the identification of new interactions between players mentioned above, which will be
involved specifically in VSVG trafficking from the Golgi to the PM, making use of a
two-hybrid system. This will finally focus my attention on the discovery of new
players in TGN-to-PM trafficking, such as elements for which a role in TGN-to-PM
trafficking might be suspected, but have not been characterized yet.
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Figure 7. The temporal steps of post-Golgi carrier (PGC) formation:
a) Segregation of the 'export' membrane from the resident Golgi domains, with the inclusion of both cargo
and machinery proteins. b) Extrusion in the form of tubules and irregular saccules and detachement c)
Transport from the parent organelle. Cyt. = cytoskeletal tracks (MT or actin), red spots = motors. The
molecular mechanisms and the exact temporal sequence within which the molecular players act on these
processes are still unclear. On right side are shown the molecular pathways, see chapter 1.2.3 for details.
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3 Materials and methods
3.1 Subcloning
3.1.1 Open reading frame (ORF) production
Five J.Lgof each plasmid DNA were digested with the appropriate restriction
enzymes (Amersham), to produce the following ORFs, that were ready to be inserted
in-frame with the activation domain (AD) ofpGAD-T7 and the binding domain (BD)
ofpGBK-T7 (Clontech). The restriction endonucleases were purchased from
Amersham Pharmacia Bio-Tec (UK). The enzymes in their order of use are as follows:
Synbindin was excised from the pEYFP-Nl plasmid with Ecokl and BamHI; the
fragment of Arapl from amino acid 552 to the amino acid 1077 was excised from the
pEGFP-CI plasmid with EcoRI; and XhoI, TGN46 was excised from the pEGFP-NI
plasmid with Ecokl and BamHI; PI4KIIa from the pGEX4-TI plasmid with Ecokl
and XhoI; 14-3-3y from the pET28A plasmid with Ecokl and XhoI; PITP~ from
pBluescript plasmid with NcoI and BamHI; FAPP2 from the pTrcHis2 plasmid with
BamHI and Sall; ARFGAPI from the pEGFP-Nl plasmid with Ecokl and Agel;
PKDl from the modified pME-Py plasmid (Liljedahl et al., 2001; Maeda et al., 2001)
with EcoRl-XhoI; PKD2 from the same vector as PKDl with Ecokl -XhoI; FAPPI
from pEYFP-Cl vector with BglII and SalI, ARLI from pEGFP-N3 vector with
EcoRi and BamHl. Bet3 from pEGFP-C3 with Bgl! and BamHI, ARLIQ71L from
pEGFP-N3 with Ecokl and BamHI. OSBPI was single digested with BamHI, and the
digested plasmid was dephosphorylated with Shrimp alkaline phosphatase (Roche) .
.When cutting sites were not available, some pairs of PCR primers (listed
below) were designed to PCR-amplify the desired ORFs. The PCR primers contained
in-frame restriction sites: EcoRI-XhoI for pGAD-T7, and Ecokl-Sall for pGBK-T7 ..
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The ORFs and the primers used to amplify them are listed below, with the restriction
sites shown in bold:
Gai3:
5'-ATAGAATTCATGGGCTGCACGTTGAGC-3' and
5'-ATAGGATCACTCGAGTCAATAAAGTCCACATTCC-3',
FAPPI-PH:
5'-ATA~AATTCATGGAGGGGGTGTTGTACAAG-3' and
5' -ATACTCGAGTGCTTTGGAGCTCCCCAG-3',
FAPP2-PH:
5' -ATAGAA TTCATGGAGGGGGTGCTGTACAAG-3' and
5' -ATACTCGAGGCAAGCCTTGGCTGATCCCAG-3',
FAPP2-.M>H:
5' -ATAGGATCCCTGACAGTAGGACCCAGAAGGAG-3' and
5' -ATACTCGAGCATGGACCTCTTATAAAGCGTCCAG-3',
Frequenin:
5' -ATACATATGATGGGGAAA TCCAACAGCAAG-3' and
5' -ATACTCGAGTACCAGCCCGTCGTAGAG-3',
DynaminII: 5'-ATAGAATTCATGGGCAACCGCGGGATG-3' and
5'-ATAGGATCCCTAGTCGAGCAGGGACGG-3',
PKD l-catalytic domain:
5'-ATAGAATTCGCAAATGTAGTGTATTATGTGGG-3' and
5' -ATACTCGAGATAGTCCTGTAGCCAAGGGTG-3',
PKD2-catalytic domain:
5' -ATAGAA TTCAA TGTGGACA TTGCCACTGTC-3' and
5' -ATACTCGAGGAGAACACTGATGCGCTC-3',
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PaId: 5'-ATAGAATTCGTGGTGACAATGTCAAATAACG-3'
and 5' -ATACTCGAGGTGATTGTTCTTTGTTGCCTC-3'.
After their amplification, the PCR products were cut out from the agarose gels
with a sterile scalpel, and the DNA was extracted from the agarose using the "QIAEX
IIextraction kit" (Qiagen, CA, USA), according to the manufacturer instructions. The
DNA was eluted in 10 mM Tris-HCI, pH 8.0.
3.1.2 Production of frameshift vectors
The pGAD- T7 and pGBK- T7 vectors (Clontech) are commercially available in one
single frame. To obtain frame-shift mutants, I performed single-step mutagenesis that
involved amplification of the entire plasmid using high-fidelity PFU-turbo DNA
polymerase (Stratagene), inserting 1 or 2 bases (in bold) between the sequences coding
for the HA-tag and the multi cloning site, with the aim of producing two alternative
frames for both vectors. For this mutagenesis reaction I used the following primers:
5'-GTACCAGATTACGCTA(A)CATATGGCCATGGAG-3' and
5' -CTCCATGGCCATATGT(T)AGCGT AATCTGGTAC-3' for pGAD- T7
and primers
5' -TCAGAGGAGGACCTGA(A)CATATGGCCATGGAG-3' and
5' -CTCCATGGCCATATGT(T)CAGGTCCTCCTCTG-3' for pGBK- T7.
The PCR reaction conditions were: 5 III buffer, lOx PFU-turbo, 20 Ilg template
DNA, 25 IlM forward oligo, 25 IlM reverse oligo, 8 III dNTPs (2.5 mM), 2.5 U PFU-
turbo DNA polymerase and sterile double distilled water to 50 III final volume. After
denaturation at 95°C for 5 min, 18 cycles followed with 95°C for 30 s, 55°C
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(annealing) for 1 min and 68°C for 9 min. DpnI was added after the PCR reaction, to
digest the metylated DNA template, for 1 hat 37°C. The final products of the two
alternative frames were named pGAD-T7-f2 or f3 and pGBK-T7-f2 or f3. In the
pGAD-T7 frame-2, a STOP codon appeared due to the frameshift. To make the
pGAD- T7 frame-2 usable, the STOP codon was removed with another point mutation
reaction using the following oligoes: 5'-
ATGGCCATGGAGGCCAGAGAATTCCACCCGGGTG-3' and 5'-
CACCCGGGTGGAATTCTCTGGCCTCCATGGCCAT-3 '
3.1.3 Ligation
After purification, eluted DNA fragments were used directly for the ligase reaction
with pGAD- T7 or pGBK- T7 (Clontech) in their native frames or in their frameshift
versions (see above). To ligate the vector and insert, -100 ng vector and -3-fold molar
amounts of insert were incubated with 1 u T4 DNA ligase in T4-DNA-ligase buffer,
for 30 min at room temperature.
3.1.4 Preparation of competent cells
These bacteria were prepared with the help of G. di Tullio (Department of Cell
Biology and Oncology, Consorzio Mario Negri Sud). A single colony of XL-l Blue
Escherichia coli bacteria was picked up from a Lurla-Bertani (LB)-agar plate (10 gil
NaCI,5 gil yeast extract, 10 gil tryptone peptone and 15 gil agar) and used to inoculate
10 ml of LB broth (10 gil NaCI, 5 gil yeast extract, 10 gil tryptone peptone). The
bacteria were grown overnight, then diluted into 190 ml fresh LB broth and incubated
at 3ToC until the optical density (OD6oo) reached 0.5. The bacteria were harvested by
centrifugation at 6000x g for 10 min at 4°C. The bacterial pellet was resuspended in
40 ml 30 mM potassium acetate, 100 mM RbCI, 10mM CaCh, 50 mMMnCh, 15%
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(v/v) glycerol, pH 5.8, and left on ice for 2 h. After centrifugation and resuspension of
the pellet in 4 ml of 10 MOPS, 75 mM CaCh, 10 mM RbCI, 15% (v/v) glycerol pH 7,
cells were stored at -80· "C in 400 p.l aliquots.
3.1.5 Transformation of the bacteria by heat shock
The DNA from the ligase reaction (10 ul) was added to 200 ul of competent bacteria
previously thawed on ice. After gentle mixing, the sample was placed on ice for 30
min and heat shocked for 90 s at 42 "C, and put again on ice. After addition of 800 p.l
LB medium, the bacteria were incubated with shaking (200 rpm) at 37 "C for 45 min.
The bacteria were then plated on LB-agar plates containing the appropriate selective
antibiotic for the correct selection of plasmid-earring bacteria, and incubated overnight
at 37 "C. The next day, an isolated bacterial colony was picked and used to inoculate 2
ml LB containing the appropriate antibiotic. The culture was incubated at 37 "C
overnight, 300 ul of 50% sterile glycerol was added to 700 ul of the bacterial culture,
which was then stored at ~80 "C.
3.2 Yeast transformation
The yeast strains used were Y187 for the pGAD-T7 vector, and AH109 for the pGBK-
T7 vector. Single colonies ofY187 and AH109 were inoculated in 5ml ofYPDA
medium (Clontech) at 30 "C overnight under aerobic conditions with vigorous
shaking. The next morning, 1 to 2 ml were added to 60 ml of fresh YPDA medium to
reach an 00600 of 0.1-0.2 0.0., then growth was continued for 4-5 h until 00600 is
0.5-0.8. It is very important for the transformation efficiency that 00600 does not
exceed 0.8, so as to be sure that the yeast cells were still in logarithmic phase of
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growth. The cells were collected by centrifugation at 2750x g for 10 min, then washed
twice in 20 ml sterile H20. Cells were then resuspended in 0.3 ml 0.1 M LiAc. In the
meantime, carrier-DNA (sonicated salmon sperm DNA) was boiled for 5 min and then
chilled on ice. The following reagents were added, in this order, and they were mixed
very gently after each addition (addition of lithium makes the cells extremely fragile):
73 ~l cells, 240 ul 50% PEG, 36 ul 1 M LiAc, 5 ~1carrier DNA (5mglml), 1 ug
plasmid DNA, H20 to a final volume of 360~1. At the end, DMSO was used to a final
10% concentration. After an incubation at 30 QC,without shaking, for 30 min, the cells
were incubated at 42 QCfor 5 min,then centrifuged in 12x75 mm polypropylene tubes
at 200x g for 30 s. The supernatant was removed carefully, and the cells were gently
resuspended in H20. These cells were plated on SD media (clontech) lacking amino
acid Trp or Leu for the pGBK clones in the AH109 strain and the pGAD clones ,in the
YI87 strain respectively.
3.2.1 Protein expression in Yeast
Transformed colonies containing pGAD- T7 and pGBK- T7 were inoculated in 7 ml of
SD-Leu and SD-Trp liquid media (Clontech) respectively, under aerobic and vigorous
shaking conditions at 30 QCuntil they reach an OD6oo between 1.0 and 2.0. The cells
. were harvested by centrifugation at 4 QCat 2700x g for 10 min, washed twice with
sterile ddH20 (centrifuging), and than resuspended in SB with SDS, boiled for 5 min,
and frozen, defrozen and sonicated, then boiled again. The samples were loaded onto
SDS-page gels and transferred onto nitrocellulose filters for Western blotting.
Monoclonal antibodies against the HA tag and the myc tag were used to detect protein
expression. In the case of ARL1, FAPP2, PI4KIIu, OSBP1 and TGN38, the antibodies
directed against them were used in Western blotting since they were available, and
since their expression was undetectable with the above antibodies.
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3.3 Two hybrid system
The yeast strains used were Yl87 for the pGAD- T7 vector, and AHl 09 for the pGBK-
T7 vector, as described above. The BD-carrying clones from the -80°C stocks were
streacked onto agar plates with DO medium without Trp (Clontech), and the AD-
carrying clones from the -80°C stocks were streacked onto agar plates with DO
medium without Leu.
Then the growth was allowed to proceed for 3-5 days at 30°C, after which the
plates were parafilm-sealed and stored at 4 QC.Every three weeks, they were
replicated by dispersing some of the cells in sterile water and streacking this onto fresh
agar plates. For the mating between yeast clones carrying baits and preys (AHl09 and
Y187 respectively), the principle was similar to that of (Zhong et al., 2003)), adapted
and scaled to this system, as follows.
To provide a pool of preys, an amount (roughly similar to half a colony of 2.5
mm in diameter) of every pGAD clone was taken and dispersed in Nx 100,...1of2x
YPDA (Clontech), where N is the number of clones. The same criteria was followed
to obtain a pool of baits, by collecting every pGBK clone. Greater amounts of empty
p-GAD-containing clones and, separately, of empty p-GBK-containing clones were
also dispersed in the same volume of YPDA. These amounts were roughly N times
greater than the amounts taken in previous step with the pGAD clones. Thus with the
aid of a combitip pipettor, 50 ul of the mixes were distributed into U-bottomed 96-well
plates: Mixl: pool ofX-pGAD; mix2: pool ofX-pGBK; mix3: empty pGAD; mix4:
empty pGBK. Than every single pGBK clone was dispersed (roughly similar to half a
colony of2.5 mm in diameter) into wells containing the pGAD pool, to look for
[nteractions, and in wells containing the empty pGAD only, as a control for
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autoactivation. Similarly, every single pGAD clone was dispersed (roughly similar to
half a colony of 2.5mm in diameter) into wells containing the X-pGBK pool, to look
for interactions, and in wells containing the empty pGBK only, as a control for
autoactivation. These plates were incubated overnight at 30°C with gentle shaking (50
rpm). The day after two or three wells per plate were chosen randomly to look for
diploid mated cells under the optical microscope. Then, using a multichannel pipette,
50 ~l of sterile water was added to samples, with 3-4 in and out pipetting used to
resuspend the cells, and finally, single drops of cells were spotted onto the
DDO/QDO/TDO plates (Matchmaker3 system, Clontech) and finally incubated at 30
°C for seven days.
Single 'submatrix' one-by-one interaction matings ofpGAD clones with
pGBK clones, and matings ofpGAD clones with pGBK empty vector, and ofpGBK
clones with pGAD empty vector as a control for autoactivation, were performed by
dispersing an amount (roughly similar to half a colony of 2.5mm in diameter) in 50~1
of 2x YPDA on 96-microwell plates; the plates were keep at 30°C OIN with 50 rpm
shaking. The next morning, the samples were plated as described above for the
pooling approach, in the same media and under the same conditions.
To repeat the stronger interaction data and to test several dilutions of the
mating product, 20 ~l of the samples were diluted 10-,20-, and 30-fold with sterile
water, and each dilution was streaked on 1/6 of a round lOO-mm diameter plate with
DDO/QDO, in the presence of2 mg/ml X-aGal (5-bromo-4-chloro-3-indolyl-a-D-
galactopyranoside ).
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3.4 Cell culture
3.4.1 Materials
African green monkey COS7 cells were purchased from American Tissue Type
Collection (ATTC, USA). Human fibroblasts (HF) were kindly provided by the
Istituto Dermatologico dell'Immacolata (IDI, Italy). HeLa cells were kindly provided
by Thierry Dubois (Institute Curie, Paris, France). Dulbecco's modified Eagle's
Medium (DMEM) and calf serum (CS) were from Invitrogen (UK). Foetal calf serum
(FCS), penicillin, streptomycin, trypsin-EDTA and L-glutamine were from Biochrom
KG (Berlin, Germany). All these reagents were purchased as lOx stock solutions. All
of the plastic tissue culture materials were from Corning (NY, USA) or Falcon (NJ,
USA). The filters with a 0.2 J.Ul1 cutoff were from Albet (USA)
3.4.2 Growth conditions
COS7 and HeLa cells were grown in DMEM supplemented with 4.5 gil glucose, 2
mM glutamine, 1 Ulml penicillin and 1 ug/ml streptomycin, and 10% FCS. HFs were
grown in DMEM supplemented with 2 mM glutamine, 1 Ulml penicillin and 1 ug/ml
streptomycin, and 10% CS. All of the cell lines were grown in a controlled atmosphere
in the presence of5% C02 at 37°C. The cells were grown in flasks until90%
confluence. To detach the cells from the surfaces of the flasks the medium was
removed and 0.25% tripsin-EDTA solution was added for 3-6 min. Medium was then
added back to block the protease action of the tripsin, and the cells were centrifuged at
450x g for 10 min and resuspended in fresh medium, and finally placed in a new
plastic flask at the desired dilution.
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3.4.3 Cell transfection
Cell transfections with Trans-It (Myrus) (which is the same molecule as Fugene) were
performed in 24-well plates at 50% to 70% confluence. A transfection mixture was
prepared by diluting the relevant DNA in OptiMEM culture medium and adding
Trans-It in a separate test-tube. The mixture was then shaken and incubated at room
temperature for 15 min. The transfection mixture (50 ul) was then added to the cells.
Cell transfection with Oligofectamine was used mainly to perform RNA
interference (RNAi), according to the manufacturer instructions. HeLa cells (10000-
12000) were plated on 24-well plate to have around 20% confluence the day after. A
mix containing OptiMEM and the relevant siRNAs was prepared with gentle shaking,
and incubated at room temperature for 7 min. At the same time, a mix containing
OptiMEM and Oligofectamine was prepared in a second tube, and after gentle shaking
it was also incubated at room temperature for 7 min. The two mixes were pooled, and
after gentle shaking, they were incubated at room temperature for 15 min, than directly
added to' the cell media. Of note, the amounts of the siRNAs and oligofectamine
varied depending on the gene that was to be silenced, according to manufacturer
instructions.
Cell transfection with electroporation was performed on COS7 cells. Five
million PBS-washed cells were mixed together with 10 ug of the relevant DNA. The
samples were cooled on ice in a sterile electroporation cuvette (0.4 cm) (Biorad, UK).
Then the cells were electroporated in a Gene Pulse Electroporator (Biorad, UK) using
the following parameters: voltage, 220 V, capacitance, 950 j.lF . After electroporation,
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the cells were immediately plated in warm media, and the day after, the cell culture
media was changed.
3.5 Co-immunoprecipitation
The following procedure was used for immunoprecipitation of both endogenous and
overexpressed proteins. COS7 cells were transfected with Arfaptin2-FLAG, Sedlin-
FLAG and PKD2wt, or a kinase-dead (KD) PKD2. After 24 h of Transfection, the
cells were washed five times with PBS and incubated with lysis buffer (50 mM Tris,
pH7.5, 150 mM NaCl, 1mM EDTA, 1% Triton X-lOO) with the addition ofa water-
soluble complete protease inhibitor cocktail (Roche), and eventually with the addition
of the phosphatase inhibitors 1mM NaV04 and 30 mM NaF. The cells were scraped
off the plates and lysed by passage (14 times) through a 25-gauge syringe needle. The
lysates were collected and centrifuged at 20000x g for 10 min at 4 QC.For
immunoprecipitation of endogenous proteins, 1 mg lysate was incubated with 3 ug
polyclonal antibody, and for the overexpressed proteins, 20 III of EZview RED anti-
FLAG M2 Affinity Gel bed resin (Sigma), was added to immunoprecipitate the
FLAG-containing proteins. In the case of the polyclonal antibody, the day after the
samples were incubated with 40 III 50% protein-A Sepharose resin slurry (Amersham)
for 1 h at 4 QCon a rotating wheel at 14 rpm. The resin was washed three times with
lysis buffer, plus two times with lysis buffer without the Triton X-lOO, and the
proteins were revealed by Western blotting using a polyc1onal antibody raised against
PKD that recognizes both PKD1 and PKD2 (Santa Cruz). An anti-GST antibody was
also used, since the various PKD constructs had a GST-TAG at the N-terminus.
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3.6 Immunofluorescence analysis by laser scanning confocal microscopy (LSCM)
Immunofluorescence samples were observed using an Axiophot fluorescence
microscope or an Axiophot, LSM5 Pascal (Zeiss) confocal microscope equipped with
40x and 63x objectives (Zeiss, Germany). Optical confocal sections were taken at 1
Airy unit, with a resolution of 512x512 pixels and exported as JPEG files. Table 3.1
lists the dilutions of the primary antibodies used for immunofluorescence.
Table 3.1 Primary antibody dilutions used in immunofluorescence
Specificity Supplier Animal Source Dilution
FLAGM5 Sigma Mouse 1:500
GST G. di Tullio Rabbit 1:150
Arfaptin2 G. di Tullio Mouse 1:800
VSVG G. di Tullio Mouse 1:700
VSVG luminal G. di Tullio Rabbit 1:400
3.7 VSVG transport assay
3.7.1 Cell infection with VSVG
The infectious stocks of the temperature sensitive mutant of vesicular stomatitis virus
(VSV) were prepared in collaboration with Antonella Di Campli (Department of Cell
Biology and Oncology, Consorzio Mario Negri Sud). For each infectious stock, the
optimal working concentrations were experimentally defined as the lowest that caused
100% infection of HeLa cells, judged by staining of the viral membrane glycoprotein
(vSVG) in immunofluorescence.
Cells were washed 3 times in serum-free culture medium and incubated with
the diluted VSV infectious stock for 45 min at 32°C. The excess virus was removed
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by washing three times, and the cells were kept in complete medium at 40 QCfor 2.5 h
to allow the VSVG to accumulate in the ER.
3.7.2 VSVG transport to the PM
After accumulation ofVSVG in the ER, the following steps were carried out in
medium with the addition of 100 ug/ml cycloheximide, which prevents neo-synthesis
of cellular and viral proteins. The cells were placed at 20 QCfor 2 h, to accumulate the
.
VSVG in the Golgi/TGN.Then the temperature was shifted to 32 QCto follow the
Golgi-to-PM transport of the viral protein. At each time point after the shift, the cells
were fixed in 4% paraformaldehyde to follow the VSVG time-course.
3.8 Glycosaminoglycan (GAG) secretion assay.
3.8.1 Materials
Xyloside and cetylpiridinium were from Sigma, eSS]-sulphate was from Perkin Elmer
(USA), Ultima Gold XR scintillation liquid was from Beckman (USA).
3.8.2 Procedure
HeLa cells were plated In 12-well plates for 80% confluence the day of the
experiment. These cells were than washed 3 times with 600 !J.ITyrode+(Ca++/Mg++)
(10 mM HEPES-NaOH, pH 7.2,125 mM NaCI, 5 mM Kcl, 5.6 mM glucose, 1.8 mM
CaCh, 1.8 mM MgCh). Five hundred !J.Iof 1mM xyloside in Tyrode+(Ca++/Mg++)
were added to each well, and the cells were incubated for 15 min at 37 QC.
Subsequently, the cells were pulsed for 15 min at 37 QC with 400 !J.I 100
!J.Ci/ml r3sS]-sulphate in Tyrode+(Ca++/Mg++) plus 1 mM xyloside. Then 500 !J.I
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DMEM, 10 mM HEPES-NaOH, pH 7.2, plus 0.1 mg/ml (w/v) BSA were added to
each well, to allow the cells to secrete at 37°C for the required times.
The cell medium was then collected and centrifuged for 5 min at 16000x g to
pellet the detached cells and cell debri. GAGs in the supernatant were precipitated for
2 h at 37°C by adding to the medium: 1 ml H20, 50 III 2 M NaCI, 500 III 4 mg/ml
chondritin sulphate in H20, and 2 ml 2% (w/v in H20) cetylpiridinium. At the same
time, 500 III 0.1 M NaOH was added to the cell layers for 10 min, to lyse the cells.
These celllysates were collected and the GAGs were precipitated for 2 hat 37°C by
adding to the cell lysate: 750 III H20, 100 III 2 M NaCI, 500 III 4mg/ml in H20
chondritin sulph~te, 2 m12% (w/v) in H20 cetylpiridinium, 250 III 1 M HEPES.
The samples were washed three times with 4 ml l % (w/v) cetylpiridinium plus
20 mM NaCI in H20 and resuspended in 500 III 2M NaCl. They were than transferred
into vials for scintillation counting, and 8 ml Ultima Gold XR scintillation reagent was
added to each vial.
After counting the. samples in a ~-counter Beckman LS 170 1, the percentage
GAG release into the medium was calculated according to the formula:
% ofrelease= cpm cell medium/( cpm cell medium+cpm celilysate)xIOO.
3.9 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
3.9.1 Assembling of polyacrylamide gels
Two 16 x 18 cm glass plates were used for assembling standard gels. The plates were
assembled to form a chamber by using two I.5-mm plastic spacers aligned along the
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lateral edges of the glass plates. The plates were then fixed using two clamps and
mounted in a plastic base, which sealed the bottom. All of the materials were from
Hoefer Scientific Instruments (Germany). The 'running' polyacrylammide gel was
prepared by mixing H20, 40% (w/v) acrylamide-bisacrylamide solution, 1.5 M Tris-
Hel, pH 8.8, 10% (w/v) SDS, to have the selected concentration of acrylamide, 375
mM Tris-Hel, 0.1% (w/v) SDS. Then, 0.06% (w/v) ammonium persulfate (APS) and
0.06% (v/v) TEMED were added, and the solution was pipetted and poured into the
gap between the plates, leaving - 5 cm for the stacking gel. N-butanol or water was
percolated to create a layer over the running gel, that was allowed to polymerize for 1
h. After the polymerization, the gel was covered with a layer of375 mM Tris-Hfll, pH
6.8, 10% (w/v) SDS, in order to have 4% (w/v) acrylamide, 125 mM Tris-Hfll, 0.1%
(w/v) SDS. Then, 0.1% (w/v) APS and 0.07% (v/v) TEMED were added and the
solution was pipetted and poured over the running gel. A 15-well comb was
immediately inserted between the glass plates and the set up was left 20 min at room
temperature for the polimerization of the acrylamide.
3.9.2 Sample preparation and running
The PAGE samples were prepared by adding SDS sample buffer to each experimental
sample, followed by an incubation at 100 °e for 5-10 min in a multi-block heater,
cooling to room temperature, a brief centrifugation and loading onto the gel. One or
two wells were loaded with Full-Range Rainbow Molecular Weight Markers or Low
Molecular Weight Markers (Amersham Pharmacia Biotech). The gel was then
transferred into the electrophoresis apparatus (Hoefer Scientific Intruments, NJ, USA)
and run under a constant current of 8 rnA (for overnight runs) or 40 rnA (for -4 h
runs).
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3.9.3 Coomassie brilliant blue staining
After the removing of the glass plates the gels were incubated in staining
solution (50% methanol, 40% H20, 10% acetic acid, 0.1% Coomassie brilliant blue)
for 2 h, washed with water, and then de-stained with 30% methanol, 10% acetic acid
for the time required depending on the intensity of the protein bands of interest.
3.10 Western blotting
3.10.1 Protein transfer onto nitrocellulose
The polyacrylamide gels from section 3.9.2 were soaked for 15 min in transfer
buffer, placed on a sheet of 3MM paper (Whatman, NJ, USA) and covered with a
nitrocellulose filter (Schleicher & Scuell, Germany). The filter was covered with a
second sheet of3MM paper, to form a "sandwich", which was subsequently
assembled into the blotting apparatus (Hoefer Scientific Instruments). The protein
transfer was at 400 rnA for 5 h, or at 120 rnA overnight. At the end of the run, the
sandwich was disassembled and the nitrocellulose filter was stained with 0.2%
Ponceau Red (Sigma-Aldrich), 5% (v/v) acetic acid for 5 min, to visualize the protein
bands, and then rinsed with 5% Acetic acid to remove the excess unbound dye.
3.10.2 Probing the nitrocellulose with specific antibodies
The nitrocellulose filters were cut into strips corresponding to the lanes of the
polyacrylamide gel with a razor blade. The strips were incubated in blocking solution
for 60 min at room temperature, and then incubated with the primary antibodies
directed against the protein of interest, which were diluted at the appropriate
concentrations in blocking solution. A list of antibodies used in this study and their
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working dilutions is provided in Table 3.2. After a 2-3 h incubation at room
temperature, or an overnight incubation at 4 °C, the primary antibodies were removed,
and the nitrocellulose strips were washed in TTBS twice, for 10 min each.
The nitrocellulose strips were then incubated for 1 h with the appropriate horse
radish peroxidase (HRP)-conjugated secondary antibodies (anti-rabbit and anti-mouse:
1:1000) and washed twice in TTBS for 10 min each, and once in TBS for 3 min. After
washing, the nitrocellulose strips were incubated with the enhanced
chemioluminescence (ECL) reagents, accordingly to the manufacturer instructions for
ECL-based detection.
Table 3.2 List of primary antibodies used for Western Blot in this study
Specificity Supplier Animal Source Dilution
PKD1,2 Santa Cruz Rabbit 1:500
GST G. di Tullio Rabbit 1:1500
Bet3 G. di Tullio Rabbit 1:10000
sedlin G. di Tullio Rabbit 1:5000
synbindin G. di Tullio Rabbit 1:10000
3.11 Preparation of antibodies
The preparation of the antibodies was performed by G. di Tullio and
M.Santoro (Consorzio Mario Negri Sud, Italy) with the procedures described below.
3.11.1 Immunization of the rabbit
One mg of the specific antigen was resuspended in 2 ml PBS (1.5 mM KH2P04, 8 mM
Na2HP04, 137 mMNaCI and 2.7 mM KCI, pH 7.4). Two ml of complete Freund's
adjuvant were added, and this mixture used to immunize New Zealand rabbits. The
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rabbits were boosted after 21 and 42 days with 1 mg antigen containing the same
volume of incomplete Freund's adjuvant. The rabbits were bled and the serum
prepared as described below.
3.11.2 Serum preparation
After collection, the blood from the immunized rabbit was allowed to clot at 37 °C for
60 min, than kept overnight at 4 °C to allow the clot to contract. The serum was
removed from the clot and the insoluble material by centrifugation at 10000x g for 10
min at 4 °C, and stored at -80 °C in aliquots.
3.11.3 Protein-A purification of IgGs
Protein-A -Sepharose resin (500 mg) were suspended in 5 ml distilled water and
packed into a column, which was then washed with 100 ml distilled water under a
constant flow. The packed resin was finally washed with 20 ml PBS, and then 2 ml of
serum from chapter 3.11.2 were loaded onto the column at 0.5 mllmin in an FPLC
system (Pharmacia Bio- Tee, UK). The resin was then washed with 30 ml PBS, and the
retained IgGs were eluted using 15 mll00 mM glycine, pH 2.5. Fractions of 1 ml
were collected and their protein contents measured by spectrometry (as part of the
FPLC system).
The six fractions containing the highest concentrations of protein were pooled
and the pH neutralised with 1 M Tris, pH 11. The protein concentrations of the pooled
fractions were determined using a commercially available protein assay kit (Biorad,
UK), according to the manufacturer instructions. Typically, this was 2.5 mg/ml.
Different dilutions of the IgGs were tested both in immunofluorescence and Western
blotting with the optimal antibody working dilutions as reported in the Table 3.2.
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3.11.4 Preparation of antibodies for microinjection
After the affinity purification (see above), the antibodies were dialysed against 70 mM
KCI, 10 mM Na2HP04, pH 7.2, for at least 4 h, using dialysis membranes with a
molecular weight cut off of 6000/8000 Da (1ml antibody in 500 ml buffer, twice).
The antibodies were quantified again, and then they were ready to be microinjected
into the cells.
3.12 Protein purification
3.12.1 His tagged proteins
The His-tagged polypeptides, such as His-BARS, were purified as follows: a
transformant colony was inoculated O/N in 4.ml LB with the appropriate antibiotic
and the day after this was diluted 1120 in the same culture media until it reached an
OD600of 0.6. Then protein expression was induced with 0.4 mM isopropyl
thiogalactoside (IPTG) incubation under shaking (200 rpm) for 2 hat 37°C.
The culture was cooled on ice for 10 min, than pelleted at 4°C in JA14 at
9800x g for 10 min. The pellet was resuspended in 4 mllysis buffer (50 mM
phosphate buffer, pH 8.0,300 mM NaCI, 10mM imidazole, 1 mglmllysozyme and
water-soluble complete protease inhibitor cocktail (Roche). The resuspended bacteria
were fast-frozen in liquid nitrogen (and eventually stored at -80°C). Then they were
defrosted at 4°C in a waterbath, protease inhibitors and 1 mglmllysozyme were re-
added, and they were incubated for 30 min on a rotating wheel at 14 rpm.
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The bacterial samples were then sonicated six times for lOs. Following the
addition of 10 mM MgCl2 and 10 ug/ml DNAse I, they were incubated for 10 min on
ice. These samples were then centrifuged at 30000x g at 4°C for 20 min, and in the
meantime the Nickel-Select (Sigma) resin was equilibrated with lysis buffer. The
supernatant was incubated with 0.5 ml resin for 1 hat 4°C on a rotating wheel at 14
rpm. The resin was washed five times by centrifugation with lysis buffer, and then
eluted in 500 J..lIelution buffer (50 mM Phosphate buffer pH 8.0, 300 mM NaCl, 250
mM imidazole) several times. The elution fractions, the crude extract, and the lysate
supernatant were all run on SDS-PAOE to check for purity and yield.
3.12.2 Glutathione-S-transferase (GST)-fusion proteins
A single colony of E. coli transformed by a pOEX vector containing the OST fusion
protein of interest was used to inoculate 100 ml LB. The bacterial culture was grown
to an OD6ooofO.6. Expression was induced with 1mM IPTO for 3 hat 37°C. The
bacteria were harvested by centrifugation at 6000x g for 10 min at 4°C. The bacterial
pellet was resuspended in 25 ml 20 mM TRIS-HCI, pH 8.0, 100 mM NaCI, 1mM
EDTA, 1 mg/mllysozyme in the presence of water-soluble complete protease
inhibitor cocktail (Roche). Triton X-lOO (1%) was added, and the suspension agitated
continuously for 30 min at 4°C, and then sonicated for 2 min on ice. The lysed
bacteria were centrifuged fo 20 min at 30000x g and the pellet was discarded.
Meanwhile, 2.5 ml of a glutathione-Sepharose resin were diluted to 40 ml and
centrifuged at 2000x g for 5 min to remove the preservative. The supernatant was
discarded, and the resin was resuspended in 20 ml PBS. This procedure was repeated
twice. The cleared bacterial lysate (see above) was then added to this glutathione-
Sepharose resin and incubated at 4 °C on a rotating wheel at 14 rpm. The resin was
washed three times with 50 ml PBS and poured into a column. The resin was allow to
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pack for 10 min, and the protein was eluted with 1 ml elution buffer (100 mM Tris-
HCI, 20 mM glutathione,S mM DTT). The eluate was collected, and this operation
was repeated an additional five times. The protein content of each of the six fractions
collected was analysed by SDS-PAGE and the fractions containing the highest protein
concentrations were pooled.
3.13 Cell microinjection
The day before microinjection, the cells were plated in glass coverslips or on glass-
bottomed Petri dishes, in normal culture medium. For microinjection of cells grown on
coverslips, the coverslips were put into small Petri dishes (3 cm diameter) containing
normal cultured medium buffered with 20 mM HEPES, pH 7.4. The Petri dishes were
then transferred to the thermo-regulated stage of an inverted Zeiss 1M 35 microscope,
and kept at the temperature required for the experimental transport protocol.
Microinjections were performed using a transjector 5246 controlled by a 5171
micromanipulator (Eppendorf, Germany), in the manual mode. The microinjection
pressure was varied, depending on the conditions of the microinjection needle and the
viscosity of the solution to be injected, in a range from 50 to 500 hPa. The
microinjection time was manually defined by the operator as the shortest necessary to
observe the propagation through the cytoplasm of a circular wave originating from the
tip of the microinjection needle. The microinjections were made in the perinuclear
area where the thickness of the cell is greater than that in the periphery. The needles
for microinjection were prepared from 1.0-mm-intemal-diameter glass capillaries
(World precision Instruments, USA), using an automatic capillary puller (Inject-Matic,
CH) with the heat controller set to 3. Microinjection needles were then loaded with 3
J.11microinjection solution containing the antibody or the protein of interest in the
68
microinjection buffer (70 mM KCI, 10 mM NaH2P04, pH 7.2). When needed, lysine-
fixable fluorescent dextran (Molecular Probes, The Netherlands) was added to the
microinjection mixture, to follow efficient microinjections. The microinjected cells
were also located by means of a grid on the coverslip (when present), or otherwise by
looking directly at the fluorescence using a lOx objective to identify the area of
microinjected cells.
3.14 Kinase assay
3.14.1 Preparation of GST -PKD (wt,KD,CA) in Cos7 cells
COS7 cells (5x106) were electroporated with 10 J.1gDNA. After 48 h, the cells in Petri
dishes were washed five times with cold PBS and preincubated with 1.2 ml RIPA lysis
buffer (50 mM Tris-Hcl, pH 7.4,1% NP-40-, 0.25% Na-Deoxycholate, 150 mMNaCI,
1 mM EDTA, 1 mM PMSF (or Pefablock, Fluka), 1 J.1g/J.11Aprotinin, 1 J.1g/J.11
Leupeptin,1 J.1g/J.11Pepstatin, 1 mM Na3V04, 1 mM NaF) at 4°C for 10 min. The cells
were then scraped and passed 3-4 times through a 1-ml syringe. The lysates were
centrifuged in 1.5 ml microcentrifuge tubes at 14000 rpm at 4 °C for 10 min in a
standard bench-top micro centrifuge. The supernatants were aliquoted (300 J.11),
quantified, and frozen immediately in liquid nitrogen, and then kept at -80°C. This
protocol usually provided enough kinase for four samples in kinase assay (as follows).
3.14.2 elp] Kinase assay
Starting from the above cell lysates, every 300 J.11aliquot was used for a single sample
in the assay. The samples were defrosted in a waterbath at 30°C and immediately
placed at 4°C when they were nearly completely defrosted. Then they were incubated
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on a rotating wheel at 14 rpm at 4°C for 1 h with 20 ul GST-Sepharose 4B resin
equilibrated with RIPA buffer. The resin was washed twice with RIPA buffer and
twice with 20 mM HEPES, then resuspended in 48 f.ll 100 mM HEPES. The sample
was added with 16 f.llof GO solution (500 f.lMATP, 5 f.lCiye2p]-ATP, 25 mM MgCh
and 100 mM HEPES) with the substrates/controls on ice (N.B. the final concentration
of ATP was 100 f.lM). The kinase reaction was started by putting the samples at 30°C
and after 10 min the reaction was stopped with sample buffer and boiled for 5 min.
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4 Results
4.1 The thematic interactome: known interactions
I started to collect interactions relevant to TGN-to-PM trafficking for several reasons.
First of all, I considered the elements present in Figure 7·for which a defined
participation in this pathway is clear. Then, I added other elements that are
significantly related, together with their interactors. I selected them from literature
mainly, and from interaction databases, such as STRING (http://string.embl.de//).In
the interaction map shown in Figure 8 it is possible to appreciate the complexity of the
resulting interaction network. What is immediately evident is the importance of some
specific elements,such as CtBP1-SIBARS, PKD and PI4KIII~, which have nodal
positions in the network. Many other elements are connected in this network (Fig. 8),
which considers only the positive, direct, and physical interactions among them. Also,
this network comprises only mammalian proteins for the sake of clarity.
There are many interesting interactions also in yeast, as shown inFigure 9. The
choice here was to keep the yeast and mammals interaction networks separate, with
the focus of the study on mammals.
4.2 The two-hybrid interaction matrix: the search for new interactions
To provide new interactions among the interesting players that can participate in post-
Golgi trafficking from the TON to the PM, I choose the elements present in Tables
4.1, 4.2 and 4.3 for two-hybrid screening, based on their potential relevance in TON-
to-PM
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Figure 8. The mammalian thematic interactome
This interaction map was created with our home-made software, to graphically collect and display only
direct and mammalian interactors. The lines represent two-hybrid direct interactions, bold lines represent
interactions confirmed by our laboratory or present in the literature. Lines marked with + or - or (P)
represent functional interactions i.e. activation, inactivation and phosphorylation, respectively. The
question mark labels the interaction between the TRAPP complex (represented as the pink area) and the
Rab family protein Rab 11; this interaction is not proven but is strongly suspected, due to the high level of
yeast-mammalian homology in both counterparts. Compare also with yeast proteins in the yeast
interaction map (Figure 9)
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Myo2p
Myo4p
Figure 9. The yeast interaction network
This network presents direct physical interactions (lines) and complexes (coloured areas) in yeast. The
red lines represent genetic interactions: In this network, the important interactions between well known
elements of yeast post-Golgi trafficking are shown, such as Ypt31132, ARF1, PIKI (PI4K homologue).
Ser3 is what we consider as the putative homologue of BARS, and it has interesting interactions with
some ARFI GAPs. Moreover, it is complexed with Drs2p, which is a 'flippase' that is involved in post-
Golgi transport. Bmhlp (14-3-3 homologue) interacts with PI4K, as in mammals. The TRAPP
complex, presented as the dark-orange area, clearly gives interesting links with post-Golgi trafficking
elements such as Ypt31, Pikl, Fkslp. Compare also with mammalian proteins in the yeast interaction
map .(Figure 8)
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trafficking. To decide the candidates for the two-hybrid study, the interaction network
in Figure 8 was particularly helpful.
The two-hybrid system has the advantage of showing only direct phisical
interactions between proteins, and the possibility to work on high-throughput basis. In
contrast, it also gives false positives, and consequently there is the need to further
confirm the positive interactions using different methods (e.g. lP, co-localization).
4.2.1 Preparation of candidates
As a first technical step for the two-hybrid analysis, I prepared the DNA constructs
(listed in Tables4.1, 4.2, 4.3) that are compatible with the two-hybrid system, thus I
performed the subcloning of the coding sequences into vectors that are suitable for the
Matchmaker3 (Clontech) two-hybrid system (see Figure 10). The two-hybrid system
allows proteins to be expressed in yeast cells fused with the activation domain (AD),
which activates the reporter gene expression on one side, and fused with the binding
domain (BD) that binds the DNA in the proximity of the promoter on the other side
(Fig. 10). Every interaction is revealed by the proximity between the BD and AD
domains, a condition that occurs if the two partners interact. The original purpose was
to subclone each gene of interest into both the AD and BD domain, and this was done
for the majority, but not for all, of the players listed in Tables 4.1-4.3 (for technical
reasons). Some of them are in only one of the two forms, as shown in Table 4.4 which
illustrates the matrix of the interactions tested in this study.
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Table 4.1 The proteins chosen for the two-hybrid screening in this study are listed,
along with their synonyms, Swiss-Prot accession numbers, aminoacidic length and
function. The clones marked with * were kindly provided in pGBK vectors by the
Sallese laboratory of the DCBO.
NAME Synonyms SwissProt Length Functioncode (AA)
Gai3 P08754 354 Signalling
Src P41239IPO 533 Signalling0523
GB/y* Signalling
Cdc42 G25K P60953 191 Signalling
PKDl* PKC~ Q62101 916 SignallingiGolgi-to- PM transport
PKD2 Q9BZL6 878 SignallingiGolgi-to-PM transport
Pak1 P65-PAK Q13153 545 Signalling
ARF1* P32889 180 Golgi maintenance and trafficking
ARL1 P40616 181
Arf-related protein that interact with
GRIP-domain of golgins
ARFGAP1 ARG1 Q62848 415 ARF1 GTPase activating protein
ARAPla CentaurinD2 Q96L71 1205 ARF1 GTPase activating protein
Arfaptin2* PORI P53365 341 ARF 1 and Arl1 interacting protein
Arfaptinl * Q2M2X4 341 ARF 1 and Arl1 interacting protein
PI4KIIIB* PI4K92 Q9UBF8 816 Phospholipid metabolism
PI4KIIa 479 Phospholipid metabolism
FAPP1 . PLEKHA3 Q9HB20 300 . Golgi-to-PM transport
FAPP2 PLEKHA8 Q96JA3 507
Glycolipid transfer activity/Golgi-to-
PM transport
OSBP1 P22059 807 Oxysterol binding protein
PLD1* Phospholipid metabolism
PITPB P53811 271 Phospholipid metabolism
14-3-3y P61983 247 Scaffold protein
GAPDH* P00354 334
Energy metabolismIBF A-ribosylated
substrate
BARS* CtBP1-S, Q9Z2F5 430
BFA-ribosylated substrate/membrane
BARS50 fission activity
VSVG P04884 511
Viral capsid protein (cargo used as a
trafficking probe )
OCRL-1* Q01968 901 Inositol polyphosphate 5-phosphatase
Dynamin II P39052 870 Membrane fission activity
Sedlin* TRAPPC2 014582 140 Component of the TRAPP complex
Bet3 TRAPPC3 043617 181 Component of the TRAPP complex
Synbindin TRAPPC4 Q9Y296 219 Component of the TRAPP complex
TGN46 043493 480 TGN -specific matrix protein
TGN38* P19814 357 TGN -specific matrix protein
Frequenin NCS-1 P62168 190 Regulator of PI4-kinase
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I also subcloned into the above vectors some selected domains present into the
following proteins: PKD, BARS, ARAP, FAPP1 and FAPP2, as listed in Table 4.2.
Table 4.2 Deletion fragments
The names of these deletion fragments are as used into the main text. The parental
proteins from which fragments were extracted are also listed here, along with the
formal name of the domain they comprise, and its position, length, and function. The
clones marked with * were kindly provided in pGBK vectors by the Sallese laboratory
of the DCBO. PKD 1CD comprises the region 589-845 previously used in a two-
hybrid experiment (Haworth et al., 2004).
NAME of
NAME Full- domain position
Length function
length (AA)
protein
FAPP1-PH FAPP1 PH 1-93 93
PIP2 binding/Golgi-to-
PM trafficking
FAPP2-PH FAPP2 PH 1-93 93
PIP2 binding/Golgi-to-
PM trafficking
diFAPP1-PH* FAPP1 PH dimer
(1-93)LLCSLL(1- 192 PIP2 binding/Golgi-to-93) PM trafficking
FAPP2w/oPH FAPP2 GLTP 97-507 410
Glycolipid transfer
activity
ARAP(552- ARAPla PH domain 552-1077 525
Stimulation of GTPase
1077) plus RhoGAP activity of ARF 1
BARS-NBD* BARS NBD 111-306 195
Nucleotide-binding
domain
Binding ofPXDLS
BARS-SBD* BARS SBD 1-111/308-430 233
motif present in
transcriptional
regulators
PKD1-CD PKD1 Catalytic 501-901 400
Substrate
phosphorylation
PKD2-CD PKD2 Catalytic 542-878 336
Substrate
I phosphorylation
Src-SH2* Src SH2 82-156 74 P-Tyr binding
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I also subcloned the small G-protein mutants in their active (GTP-bound)
forms, since it is well established that they preferentially interact with their
partners/effectors when they are bound to GTP instead ofGDP. These are listed in
Table 4.3
Table 4.3 The active form mutants of GTPases used in the two hybrid assay,
together with the name of their mutant forms, effectors and functions.
Name Mutant form
Effectors in GTP Specific Function
form
Retrograde trafficking
Arfaptinl,2, COPI, Golgi-ER, Chlatrin-
ARFI-GTP Q71L adaptor proteins mediated transport
(APs), FAPP from the TGN, TGN-
to-PM
Arfaptin2, Recruitment of GRIP-
ARLI-GTP Q71L Golgin97, domain matrix
Golgin245 proteins to the TGN
Actin regulation,
Cdc42-GTP V12 Wasp, PaId, COPI
enhancer of
polarization state,
basolateral transport
Finally, 34 candidates as 'bait' vectors and 29 candidates as 'prey' vectors
were prepared in the Matchmaker3 System (BD Clontech) for the two-hybrid assay
(Table 4.4). These were made, where possible, with the classical cut and paste
procedures using restriction enzymes. When this was not possible, I designed
oligonucleotides plus restriction sequences to PCR-amplify the ORFs. After ligase
reactions and transformation of the E. coli, several clones from every single candidate
were checked on agarose gels, to assess the presence of the correct-weight digested
fragments. I then sequenced their ORFs in the 5' direction, starting from the T7
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promoter upstream of the multi-cloning site, to check for their correct orientation and
frame.
Subsequently I transformed the YI87 and AHI09 yeast strains (provided with
the Matchmaker3 System) with the Gal4 activation domain (AD)-fused proteins and
with the DNA binding domain (BD)-fused proteins, respectively (see Methods, section
3.2). Both the AD and BD were fused at theN-terminus of the subcloned ORFs.
4.2.2 Protein expression testing
I used Western blotting to check the protein expression of the yeast clones grown to
stationary phase, using antibodies against the HA and Myc tags, which were present at
the N-terminusofthe subcloned ORFs (Fig. 10). In some cases, protein expression
was not detectable due to several factors, such as proteolytic degradation or toxicity.
In these cases, I checked the DNA sequence of the ORFs also in the 3'direction,and
in parallel I performed a second round of at least three different yeast-transformed
clones, with both anti-tag and protein-specific antibodies ..when available, such as in
the case of ARLI, FAPP2, PI4KIIa., OSBPI and TGN38. Table 4.4 shows the yeast
clones that were finally available for the two-hybrid assay, and thus the interactions
tested among them included up to 986 possible combinations. Proteins for which the
expression in yeast was not detected were also considered (grey area of Table 4.4).
4.2.3 Advantages of the two-hybrid matrix strategy
The use of the full-length proteins crossed in a two-hybrid interaction matrix, as used
here, is much more advantageous compared to a classical two-hybrid library screening
for four main reasons: (i) first and most important reason is the need for the correct
. folding of the protein, which is much more likely to occur when the polypeptide chain
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Bait Vector
a) pGBKT71.3 kb
b)
Library Vector
pGADTl
8.0 kb
AOE1, HI5~.lacl. MEl1 1'No-Hybrid Interaction
__ &"I':r;\_ GAL1 TATA HID r--
-wa.,.,iNf- r--GAL2TATA ADE.2C) AH'1og,
__wll",,_ r--MEL1 TATA MELt
)
Figure 10. The two-hybrid principle
As shown in the Materials and Methods, the first step for every two-hybrid system is the subcloning
of the genes of interest into vectors that allow their expression in yeast (a). When the two vectors are
in the same yeast diploid cell after the mating of the two strains (one with pGAD, the other with
pGBK) the two fusion proteins (b) enter the nucleus and (after a positive interaction) the activation
domain (AD) and the binding domain (BD) activate reporter gene expression (c), here shown as
His3, Ade2, Mell. For further details, see Materials and Methods in section 3.3
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is complete and not in a truncated form; (ii) the second reason is the significant
decrease in false-positive results that are due to interactions with 'sticky' misfolded
portions of truncated domains; (iii) the third reason is the reduction of false-negative
results due to the presence of several interacting motifs spread along several positions
that fall into sometimes very distant domains, which makes mandatory to have a full-
length polypeptide in this case; and (iv) the last reason is that in a library screening,
not all of the clones present in the library are expressed to the same level, thus
resulting in the exclusion of some (potentially interesting) interactions that are
undetected or below a threshold that is overcome by many other clones. This arises
because in a library screening the selection is based on quantitative activation of
reporter genes, which often depends on the amount of the expressed interacting
peptides.
Considering a two-hybrid interaction matrix, which is, as in this case, a
collection of prey and bait full-length clones that here provide a high number (986) of
testable interactions (Table 4.4), there is a way to reduce this time-consuming, high-
throughput laboratory work. I set up for our purpose a two-hybrid strategy that was
originally developed for the construction of large protein interaction maps (Zhong et
al., 2003), which allowed the discovery of new interactions in a more rapid way when
compared to the single, one-by-one crossing of the whole clone collection, which has
also been applied by M. Vidal to a huge human-clones collection (Rual et al., 2005).
This strategy consists of the pooling of yeast clones that contain the AD-fused
proteins (on the one side) and in the pooling of the yeast clones containing the DNA-
binding BD-fused proteins (on the other). Subsequently, individual AD-clones were
mated with the BD pool, and vice-versa, individual BD-clones were mated with the
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AD pool. As a first step, I obtained single AD and BD clones that showed positive
interactions (with any other counterparts in the respective pool) that had not been
identified yet.
To determine which interacted with which, these 'incomplete' results were
used to design a 'submatrix', which consisted of the single protein-protein crossings
between the AD- and BD- positive clones from the above screening. This 'submatrix'
contained 154 possible interactions, all of which were tested one by one in 96-well
plates, to determine who interacts with whom. A schematic view of the strategy is
shown in Figure 11. This approach was useful, since I tested six-fold fewer single
interactions, compared to the full matrix in Table 4.4 that comprises 986 possible
crossmgs.
4.2.4 Confirmation of results
All of the binary interactions resulting from this two-hybrid approach were tested
again with serial dilutions (not shown), and Table 4.5 reports only the positive,
confirmed results. The positive clones were plated in QDO plates (see Materials and
Methods, section 3.3) for the control of the expression of three reporter genes, and in
parallel they were plated also in TDO plates, for the assessment of only two reporter
genes, in order to also reveal any weaker interactions.
The interaction strengths in Table 4.5 depended mainly on this difference, and
also on the growth levels. The interactions that activate all three of the reporter genes
present in the Matchmaker3 (Clontech) two-hybrid system (see Materials and
Methods, section 3.3) are likely to be stronger, and are less likely to be false negatives.
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Prey interact with 7Baits Bait interact with 7Preys
Bet3 Pool of baits BARS Pool of preys
PKD2 Pool of baits Cdc42 Pool of preys
TGN46 Pool of baits Sedlin Pool of preys
Synbindin Pool of baits OCRL Pool of preys
ARFGAP1 Pool of baits Src-SHD2 Pool of preys
ARL 1-GTP Pool of baits 14.3.39 Pool of preys
ARAP1 (552-1 077)Pool of baits a) Arfaptin1 Pool of preys
PITPb Pool of baits FAPP1 Pool of preys
PKD2-CD Pool of baits BARS-NBD Pool of preys
ARL1 Pool of baits ARL 1-GTP Pool of preys
FAPP1 Pool of baits Arfaptin2 Pool of preys
Pak1 Pool of baits
OSBP1 Pool of baits
Bet3
PKD2
TGN46
Synbindin
ARFGAP1
ARL 1-GTP J----+---+-+----+---4-+--+---+-+--f-----1
1(552-10771----+---+_+----+---4_+--+---+_+--f-----1
PITPb
Synbindin
PKD2-CD
ARL1
FAPP1
Pak1
OSBP1
Figure 11. The two hybrid strategy
This scheme summarizes the approach used to discover new interactions using a two-hybrid system. (a)
Single clones with the activation domain (AD) are each crossed with the binding domain BD pool, and
vice-versa for all of the BD clones versus the AD pool. The proteins (out of the total) that give positive
results by interacting with at least one of their counterparts in the pool are shown. (b) To identify which
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Bet3
baits IS
reporter
genes
3Sedlin ++++
n2 ++++ 3
PKD2-CD Sedlin ++++ 3
PKD2
ARL1-GTP
+++ 3
+++ 3
BARS-NBD +++
----'1----+
3
BARS ++
Cdc42-GTP
Cdc42-GTP
3
2
+ 2
2
+
+
2
2
Table 4.5 two-hybrid interactions
The newly discovered interactions between the activation (AD)- and binding domains (BD)-fused proteins. These came
from the high-throughput strategy described in the text, after their confirmation in single experiments in which they
were crossed again and tested again for growth, with all of the auto activation controls (righthand columns). The results
are ordered following the strengths of the interactions (rs= interaction strenght). Thus, the interactions between baits
and preys, namely the AD- and BD-tagged clones, that allow the growth on plates with QDO media came first, since the
QDO plates allow for the growth of the clones that activate all ofthe three reporter genes (see Methods, section 3.3). At
the bottom part of the Table, there are the interactions that allow for the growth on TDO media plates, because they
activate two of the reporter genes (see Methods, section 3.3).
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Figure 12. Adding in the novel mammalian interactions
The novel two-hybrid interactions from Table 4.5 are shown in red. PKD appears to be an important
hub towards which many pathways converge. Arfaptins 1 and 2 also occupy a central position in the
network, even if their functional roles are not fully clarified yet. TRAPP is also well connected in the
network via its components Sedlin and Synbindin.
)
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What also should be noted is that a quantitative difference cannot be directly
related to the strength of the interactions themselves, since the detectability of the two-
hybrid system can vary according to several factors: first, the protein expression levels
of the two interacting partners can vary from one case to another; then, the topology of
the interaction partners on the DNA molecule at the level of the promoter can vary.
This latter is responsible for the activation of the reporter genes. Also responsible for
the activation of the reporter genes is the level of entry of the AD or BD domain
chimera into the yeast nucleus, and the Km of the individual interactions themselves,
which can be very stable or very transient, depending on the case. Thus, the
correlation between strength of interaction and level of activation of the reporter genes
can be masked by the variables indicated here and thus the growth strength seen in a
two-hybrid system cannot be directly related to the biology of the interaction.
4.3 Enriching the TGN-to-PM interaction network
As a first use of the newly discovered interactions·, I inserted them into the interaction
network shown in Figure 8. As is clearly seen, the nodal proteins PKD, Arfaptin, and
14-3-3y dramatically become "more nodal" than before when these novel interactions
are considered (Fig 12). The TRAPP complex, which was suspected to be linked to
post-Golgi routes in yeast, appears to be even more strongly linked to the post-Golgi
stages, due to the new PKD-Sedlin interaction, as shown in the hybrid map that
'combines the yeast and mammal interactions together (Fig. 13), Moreover, theTRAPP
complex subunit Synbindin interact with 14-3-3y, and this interaction also contributes
to this direction. The fact that this map is hybrid (yeast and mammals) is also very
helpful, and it is justified since the TRAPP complex is particularly conserved between
species (Table 4.6).
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Figure 13. The TRAPP interactions in yeast and mammals
The interactions around the TRAPP complex (within the orange border) are collected together in this
interaction map, for both yeast (yellow) and mammals (cyan). The novel interactions (PKD2-Sedlin,
14-3-3y-Synbindin) contribute to the concept of TRAPP as a post-Golgi player. Black lines represent
direct interactions, cyan lines represent genetic interactions in yeast and coloured areas represent
)complexes.
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4.4 Going deeply into some binary interactions
The two-hybrid system provides information on binary interactions, even if, as widely
accepted, there is the possibility of false positives. However, the Matchmaker3 system
(Clontech) that I used is designed to dramatically reduce the number of false positives,
and this is especially true for the interactions that activate all three of the reporter
genes (see Table 4.5). Moreover, the promoters of these reporter genes are located in
different independent areas of the yeast genome. Nevertheless, there is always the
need to confirm the protein-protein interactions with different experimental
approaches. Thus, I decided to confirm some of them. In the present section I describe
the functional implications of these interactions, thus providing a rationale for their
choice among all of the two-hybrid data shown in Table 4.5.
4.4.1 Arfaptin interacts with Arll
The direct interaction between the small O-protein Arf-like protein 1 (ArIl)-OTP and
Arfaptin2 turns out to be a positive control into our two-hybrid data set because it was
already known (Van Valkenburgh et al., 2001). Thus this particular interaction is
already confirmed by previous studies. Arl1 is highly similar to the well characterized
small O-protein Arfl (Beraud-Dufour and Balch, 2001; Donaldson et al., 2005);
however, its precise functional role is still not known. Arl1 has an exclusive
localization at the TON, as has been shown by immunofluorescence and EM (Burd et
al., 2004). The Q71L mutant of Arl l is not able to hydrolyze OTP, and thus it remains
in its active/membrane-bound form. At present, nothing is known about the function
of this Arl l (Q71 L)-Arfaptin2 interaction.
The Arfaptins (1 and 2) have a BAR domain that has been structurally
determined (at least for Arfaptin2) as a membrane-curvature-promoting and/or sensor
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domain (Peter et al., 2004). This feature is interesting, because as it might have a role
in the process of membrane bending and the subsequent budding, it can be
hypothesized that Arll is an anchor for the TON localization of Arfaptin, which would
favour the activity of Arfaptin on carrier formation, which is the first step inTON to
PM transport (see Introduction, section 1.2).
4.4.2 Arfaptin interacts with PKD
Another interesting interaction that comes from the two-hybrid assay occurs between
Arfaptin2 and PKD2. The three PKD isoforms PKD 1,2 and 3, ate Ser-Thr kinases
that are involved in trafficking at the level of TON to PM trafficking, and their kinase
activities are necessary for membrane fission, (Liljedahl et al., 2001; Yeaman et al.,
2004).
With the use of confocal microscopy, we have seen that Arfaptin2 co-localizes
with the TON compartment marker TON46 (Figure 21), and we know using immuno-
EM that it is mainly TON-associated (De Matteis laboratory, unpublished
observations). Arfaptinl is strongly similar to Arfaptin2, and it was discovered later,
despite its name. The overexpression of Arfaptinl is inhibitory for the secretion of
metalloproteinase 9 (MP9), a constitutive cargo that is directed to the PM (Ho et al.,
2003). The transport ofMP9 is known to be mediated by the phorboI12,13-dibutyrate
(PDB)-activated form ofPLD, and PLD is known to be inactivated by Arfaptinl
everexpression (Williger et al., 1999). PDB is one of the family ofphorbol esters,
which are known to mimic diacylglycerol (DAO) activity and to recruit and activate
PKD on the TON.
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Moreover, Arfaptin 1 and 2 can heterodimerize, as also demonstrated with our
two-hybrid system (see Table 4.5). Considering that PKD is activated by PDB as well,
and that an active pool of PKD is important for membrane fission, a parallel
mechanism can be hypothesised for a role for the Arfaptin2-PKD interaction, where
Arfaptin2 can have a regulatory role on the activity that PKD exerts on transport. This
fits with the idea that Arfaptin via its BAR domain, can be important for the first step
(membrane deformationlbudding) of the process, maybe by blocking the activity of
PKD on membrane fission which has to occur 'only when a completely mature carrier
is formed.
To confirm the two-hybrid interaction between Arfaptin2 and PKD2, my first
attempt was to co-immunoprecipitate overexpressed Arfaptin2-FLAG together with
the wild-type or kinase dead (KD) PKD2 (Fig. 14). The co-overexpression of
Arfaptin2-FLAG and GST-PKD2 clearly showed co-immunoprecipitate in vivo, as
revealed by the antibody for the GST tag in Western blotting of the anti-FLAG
immunoprecipitate. In parallel, the immunofluorescence analysis showed co-
localization between Arfaptin2 overexpressed with a FLAG tag and GST-PKD2 in the
perinuclear area of HeLa cells (Fig. 14 C).
Encouraged by the above result, I subsequently attempted to co-
immunoprecipitate the endogenous proteins in HeLa and COS7 cells using specific
'antibodies. Thus, I performed immunoprecipitation of Arfaptin2 in the cell lysate with
1% Triton with anti-Arfaptin polyclonal antibody. Western blotting with a PKD
specific polyclonal antibody (Santa Cruz) showed a band of 100 kDa were Arfaptini
immunoprecipitate was present, corresponding to the molecular weight expected for
PKD (Fig, 15). This antibody does not allow a distinction between PKDl and 2 (that
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Figure 14. Arfaptin and Sedlin co-immunoprecipitate PKD mainly in its functional, wild-type form
COS7 cells were co-transfected with Arfaptin2-FLAG and GST-PKD2 in the wild-type or in the kinase
dead (KD) form, than the celllysates were immunoprecipitated with the EZ view RED Anti-FLAG
(SIGMA) antibody on affmity resin (see Methods, section 3.5). (A) Western blotting showing the GST
signal in the input lysate and in the flow-through of the GST-PKD2-wt cooverexpressed with Arfaptin2-
FLAG (a input, b flow-through), and of the GST-PKD2-KD cooverexpressed with Arfaptin2-FLAG (c
input, and d flow-through), and the GST signal in the immunoprecipitate in the presence of GST-PKD2-
wt or GST-PKD2-KD (e and f, respectively). Western blotting with the anti-FLAG antibody shows the
presence of the Arfaptin2-FLAG in the corresponding lanes. (B) COS7 cells were co-trasfected with
Sed lin-FLAG and GST-PKD2 in the wild-type or in the KD form, than the celllysates were
immunoprecipitated with the EZ view RED Anti-FLAG (SIGMA) antibody on affmity resin (see
Methods, section 3.5). A pull down with anti-FLAG in cells overexpressing only GST-PKD provided a
negative control for both A and B: western blotting shows the GST signal in the input lysate and in the
flow-through (g and h, respectively) and in the immunoprecipitate (i). Western blotting of the GST signal
in the input in presence of Sed lin-FLAG plus GST-PKD2-wt (1) or GST-PKD2-KD (m). Western
blotting of the GST signal in the anti-FLAG immunoprecipiate in the presence of Sedlin-FLAG plus
GST-PKD2wt (n) or GST-PKD2-KD (0). Western blotting with the anti-FLAG antibody shows (below)
the presence of the Sed lin-FLAG in the corresponding lanes. (C) In confocal sections, Hela cells co-
transfected with Arfaptin2-FLAG and GST-PKD2-wt shows co-localization in the perinuclear area.
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have a high homology, especially in their catalytic/substrate recognition domains),
since it was raised by immunizing a rabbit with a common N-terminal peptide.
Interestingly, the Arfaptin-PKD interaction is dependent on the presence of
phosphatase inhibitors (Fig. IS).
4.4.3 Sedlin interacts with PKD
Another interesting interaction that I discovered with the two-hybrid assay occurs
between Sedlin and PKD2, via the PKD2 catalytic domain. Sedlin is part of the
trafficking protein particle (TRAPP) complex, both in yeast and in mammals (Gavin et
al., 2002), and the TRAPP complex is characterized as a tethering factor for ER-to-
Golgi trafficking (Sacher et al., 1998); (Loh et al., 200S);(Yu et al., 2006).
Interestingly, from the medical point of view, the Sedlin gene is mutated in
IDJondilo~hiphiseal gisplasia late (SEDL), a chondro-dysplasia that involves
condrogenesis impairment (short stature, barrel chest, spine deformation) (Shaw et al.,
2003).
Interestingly, in yeast Sedlin is part of both the TRAPPI and TRAPPII
complexes, which are different complexes that contain particular elements: basically
TRAPPII is TRAPP I (seven components: BetSp, Trs20p, Bet3p, Trs23p, Trs31 p,
Trs33p, Trs8Sp) plus three other components (Trs6Sp, Trsl20p, Trs130p) (Sacher et
al., 2000), as shown in Table 4.6. There is a lot of evidence implying that TRAPPII is
'relevant in the late-Golgi pathways in yeast: first, its GEF activity on ypt31132, which
is important for constitutive exocytosis (Liang et al., 2007); then also relevant,
synthetic lethality is seen for both the TRAPPII-specific component Trs6Sp and the
shared component Trs33p, with phosphoinositide 4-Kinase Piklp (Sciorra et al.,
200S); I!l0reover the TRAPPII-specific component Trs130p co-fractionates with
92
Arfaptin21P Sedlin IP
e h
+ Ph. Inhib.
I m n
OOkDaPKD
- Ph. Inhib.
Arfaptin2
100kDa PKD
43kDa Sed lin 14kDa
Pre-immune IP
s t
PKD -+
Sedlin
Figure 15. Endogenous Arfaptin and Sedlin co-immunoprecipitate with PKD
Immunoprecipitations of the endogenous Arfaptin2 and Sedlin proteins (left and right, respectively)
were performed with the respective rabbit polyclonal antibodies in Hela celllysates with 1% Triton
X-lOO, using Protein A Sepharose. The immunoprecipitation was carried out with or without
phosphatase inhibitors (sodium fluoride and activated sodium orthovanadate) as indicated (-1+ Ph
inhib). Lanes a and b, e and f, i and I and 0 and p are duplicates of the immunoprecipitates. Lanes
c,g,m,q are the flow-throughs after immunoprecipiation and d,h,n,r are the input Iysates. The
polyclonal antibody (Santa Cruz) against PKD (1 and 2 without distinction) shows a band
corresponding to the molecular weight ofPKD, indicating co-immunoprecipitation of the PKD,
which is decreased with Arfaptin2 immunoprecipitate in the presence of the phosphatase inhibitors.
Immunoprecipitation of the same cell lysate with Pre-immune IgG, s input, t immunoprecipitate.
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Chs3p, which is a late Golgi and early endosome marker, and when Trs130p is
knocked-out invertase accumulates inside the Golgi complex (Cai et al., 2005).
Moreover, the functional data on the TRAPPII-specific component Trs120p is also
relevant: Cai and co workers (Cai et al., 2005) characterized Trs120p as a factor that is
required for the recycling ofSnc1p and Chs1p from early endosomes to the late Golgi.
In the light of these considerations, it will be interesting to investigate a possible role
of Sedlin as part of TRAPP II in post-Golgi trafficking, even though the TRAPPII-
specific components in mammals are only putative on an in-silica basis (Cox et al.,
2007), and this is not sufficient to definitely establish its existence in mammals.
However, between mammals and yeast, the TRAPPI components share a high
level of homology, as shown in Table 4.6. Thus considering that basically TRAPPII in
yeast is TRAPP I plus three additional components, it cannot be excluded that TRAPP I
in mammals acts as TRAPPII, but via different adaptors/machinery, such as PKD.
To confirm the two-hybrid interaction between Sedlin and PKD2, first of all I
co-immunoprecipitated Sedlin-FLAG overexpressed together with the wild-type or
KD forms ofPKD2 (Fig. 14). The co-overexpressed Sedlin-FLAG and GST-PKD2
clearly co-immunoprecipitated in vivo, as shown by the antibody for the GST tag in
the Western blotting of the anti-FLAG immunoprecipitate.
Subsequently, encouraged by the above result, I tried to co-immunoprecipitate
the endogenous proteins in HeLa and COS7 cells using specific antibodies. Thus, I
performed the immunoprecipitation of Sedlin in celllysates with 1% Triton with an
anti-Sedlin polyclonal antibody. The Western blotting with the PKD-specific
polyclonal antibody showed a band of 100 kDa in the Sedlin immunoprecipitate,
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Subunit Yeast Human AA TRAPP TRAPP
(# of AA) (# of AA) identity I II
Bet5 159 145 30% + +
Trs20 175 140(SEDL) 40% + +
Bet3 193 180 53% + +
Trs23 219 219(Synbindin) 30% + +
Trs31 283 188 27% + +
Trs33 268 160(Trs33A) 24% + +
158(Trs33B) 33%
Trs65 560(Kre 11p) - - - +
Trs85 698(Gsglp) - - + +
Trs120 1289 - - - +
Trs130 1102 1259(EHOC- 12%(28%) - +
I/GT334)
Table 4.6
Homologies between the yeast and human TRAPP complex subunits
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which corresponds to the molecular weight expected for PKD (Fig. 15). This antibody
did not allow a distinction between PKDl and 2, as described above. Interestingly, and
as shown in Figure 15, the interaction was not dependent on the presence of
phosphatase inhibitors, as was the case for the Arfaptin2-PKD2 interaction.
In our two-hybrid assay, another direct interaction occurred between two
mammalian subunits' of the TRAPP complex: Bet3 and Sedlin, as it happens in yeast,
as revealed by a two-hybrid analysis (Ito et al., 2001). This interaction is not
surprising, since both Bet3 and Sedlin share more than 40% identity with their yeast
counterparts, and since they are the most conserved among all of the TRAPP· subunits
(see Table 4.6).After our discovery, this direct interaction was also seen between
mammalian Sedlin and Bet3 via a gel-filtration approach (Menon et al., 2006), and
thus it can be considered as a well confirmed direct interaction between two
components within the same protein complex, and this provides important information .
concerning the internal organization of the complex itself.
4.4.4 CtBPl-SIBARS interacts with PKD
In the case of the PKD-BARS interaction, I tested the kinase activity ofPKD on His-
BARS as substrate. Since I had the recombinant protein, it was technically possible in
this case, while in the case of His-Sedlin instead, it was not possible due to the
absence of enough of the pure recombinant protein. I expressed GST-PKDl in COS7
'cells and I then purified it directly from the cell lysate (see Material and Methods
section 3.14.1), since it is not at present possible to obtain a recombinant PKD from
bacteria. I performed a classical kinase assay with the use of radio-labelled ye2p]-
ATP, testing BARS and some of its deletion mutants together with PKD in its wild-
type and KD forms as controls. As shown in Figure 16, the results here are interesting,
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since BARS is phosphorylated in vitro and the nucleotide-binding domain of BARS
(BARS-NBD) is the most phosphorylated domain among all of the other domains
tested: A, E, C, NBD and SBD (see in Figure 16 for details). However, the E fragment
that contains the NBD plus an additional122 amino acids at the C-terminus is not
phosphorylated. This may be explained as a structural problem of the additional122
amino acids that can cover the phosphorylation site, possibly due to incorrect
dimerization since it is known that BARS homodimerizes. NBD is also the domain
that interacts with PKD2 in our two-hybrid system. Unfortunately, the kinase used for
the phosphorylation assay was PKD1, because itwas the only one available in a
functional form, although it is of note that PKD 1 and 2 are very similar, and
especially in their C-terminal catalytic domains (>80% identity).
I observed PKD autophosphorylation as the positive control of the catalytic
activity, and I observed a clear phosphorylation signal on BARS, calculated to be
0.1% of the total protein.
To check the specificity of this phosphorylation, I tested several randomly
chosen proteins as other potential PKD substrates, testing them with BARS and GST
in the same set of experiments. I thus tested purified G-~y,phosphorylase B, albumin,
ovalbumin, carbonic anhydrase, trypsin inhibitor and a.-lactalbumin. None of these
was phosphorylated by PKD (Fig. 17).
Of note, in these experiments, I tested purified G-~y also in the presence of
BARS, and I observed a clear 5-fold decrease in the phosphorylation signal of BARS
in the same experiments. This thus indicates G-~y interference in PKD-mediated
BARS phosphorylation (Fig. 16).
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Figure 16. PKD phosphorylate BARS in vitro
BARS is phosphorylated by PKD, as revealed by y[32P]_ATP phosphorylation assays (see Methods, section 3.14).
The ~y dimer ofheterotrimeric G proteins (purified from bovine brain) inhibits this BARS phosphorylation
mediated by PKD without affecting the activity ofPKD, as shown by the PKD autophosphory1ation signal.
Autoradiograms showing the phosphorylation signal on BARS (arrow) in the upper panels, and on several BARS-
deletion mutants in the lower panel: A = 1-111, E = 112-430, C = 306-430, NBD = 112-308, SBD = 1-112/307-430.
BARS and BARS fragments are indicated by arrows, PKD autophosphorylation signals are on the top, KD is kinase
dead form of PKD.
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Phosphorylase B (97.4 kDa) --+
Albumin (66.2 kDa) ---+
Ovalbumin (45 kDa) ~
G~y (35 kDa) ----+
Carbonic anhydrase (31 kDa) ~
Trypsin inhibitor (21.5 kDa) ~
a-lactalbumin (16 kDa) ~
Figure 17. PKD does not phosphorylates a mix of 7 proteins
(a) Purified G-~y, phosphorylase B, albumin, ovalbumin, carbonic anhydrase, trypsin inhibitor and
a-lactalbumin were all tested in the same reaction with PKD in the same conditions as in Figure 17
(see Methods, section 3.14). Their position is indicated by arrows. (b) PKD alone
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PKD is known to exert its activity on Golgi fragmentation through regulation
mediated by G-~y. Indeed, G-~y alone can fragment Golgi membranes in
permeabilized cells, and PKD inhibitors can reverse this effect (Jamora C. et al. 1999).
At present, an open question is: why does G-~y inhibit BARS phosphorylation by
PKD? In the presence ofG-~y, the autophosphorylation signal ofPKD is not affected,
and thus this effect is more likely to be due to an interaction between G-~y and BARS;
indeed, we assume that they do interact from the observation that the ADP-
ribosylation of BARS is inhibited by G-~y (Di Girolamo M. et al. 1995).
The phosphorylation of BARS is very interesting, since BARS exerts its effects
on TGN-to-PM trafficking of the cargo molecule VSVG at the fission step (Bonazzi et
al., 2005), and this is the same phenomena that was seen by Malhotra and colleagues
with PKD using dominant-negative PKD-KP which decorates the TGN-originated
tubules that are impaired in fission (Liljedahl et al., 2001; Yeaman et al., 2004).
Later, the interaction between BARS and PKD was further confirmed with co-
immunoprecipitation by a colleague (Carmen Valente, Corda laboratory, unpublished).
4.5 PKD as a key protein
PKD thus appears to have many interesting interactors, and this is the reason why we
believe it is an important hub into the interaction map in Figure 12: it interacts with
PI4KIII~, PKC, and the ~y subunit ofheterotrimeric G-proteins. From our recent
work, itis now clear that it also interacts with Sedlin, BARS and Arfaptin2. Every one
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of these PKD interactors is important in our research focus because PKD acts as a
fissioning player at the level of GPCs. The most interesting interaction here is the
phosphorylation of BARS, since Arfaptin and Sedlin have not yet been characterized
from the trafficking point of view. BARS, instead, is known to be relevant in the
specific step of fission ofVSVG-containing carriers when they originate from the
TGN (Bonazzi et al., 2005). In the following sections, I will describe in detail the roles
in transport also of Arfaptin and Sedlin, and thus I have started.to discover new
interesting functions of these proteins; functions that were previously unknown from
the trafficking point of view.
4.6 Arfaptin
4.6.1 Arfaptin possesses a BAR domain
The controlled bending of membranes is crucial for many fundamental cellular
processes including membrane trafficking. The transfer of material between organelles
depends on physical changes in the membranes that are mediated, in part, by vesicle-
coat proteins, such as COPI, COPII and clathrin. Coat proteins bind to a donor
membrane and then polymerize. Coincident with their polymerization, the membrane
deforms into a bud, which then separates from the parent membrane, thus forming a
transport intermediate. The possible protein-based mechanisms involved include
curvature-inducing proteins, such as the BAR family members. Among these, the
'r-BAR protein is known to associate with the TGN (Neubrand et al., 2005), as is
Arfaptin2 (Peter et al., 2004), and possibly endophilin B (Farsad et al., 2001).
Moreover, the aforementioned GRIP domain-containing proteins (section 1.2.2) have
also been proposed to be involved in membrane tubulation (Gleeson et al., 2004),
although their mechanisms of action have yet to be established.
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The effectors of Arll at the TGN include the Arfaptins and the GRIP-golgins
p97 and p230. The three-dimensional structure of the BAR domain of Arfaptin senses
and/or induces positive membrane curvature (Tarricone et al., 2001). Moreover
Arfaptin is present in the tubular compartment but not in the stacks (De Matteis
laboratory DCBO, unpublished) suggesting that the peculiar curved and tubulated
structure of the TGN is where Arfaptin functions. Arfaptin can interact with several
small G-proteins: Arfl and Arll, and also Rac1 (Tarricone et al., 2001). The
interaction with the small Gsprotein occurs, at least with Racl, through the concave
side of the BAR domain, and thus it is likely to regulate the function of the BAR-
domain itself, preventing its association with membranes. In other words, Arfaptin is
not active when it is not at the TGN, and needs to be recruited to the TGN by small G
proteins such as Arl1. The interaction with Arl1 is clear, and itwas also reproduced by
the two hybrid-system here.
The BAR domain of Arfaptin is located at-the C-terminus of this protein. From
structural comparisons and from the high level of conservation between the C-
terminus of Arfaptin2 and Arfaptin1 (Figure 18) it appears likely that the
heterodimerization of the Arfaptins 1 + 2 is compatible with the formation of an active
BAR domain conformation (Figure 19). Here in the two-hybrid interaction between
Arfaptin1 and Arfaptin2, the same growth pattern as for the homodimer Arfaptin2-
-Arfaptinz was seen (fable 4.5), indicating the same interaction strength. It has been
shown that the effects on artificial membranes were clearly due to membrane-bending
effects that produce highly tubulated membranes starting from artificial large
unilamellar vesicles (LUVs) (peter et al., 2004) (Figure 20). Once overexpressed,
Arfaptin localizes to many tubules from the perinuclear area as I have seen in vivo at
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Arfaptin 1 MAQES-PKNSAAEIPVTSNGEVDO-SREHSFNRDLKHSLPSGLGLSETQITSHGFIlNTKE 58
.: .. :::.. ::: a _. • • ... .. . . ..
Arfaptin 2 MTIlGILGKAATMEIPIHGNGBARQLPEDDGLEQOLQQVMVSGPNLNETSIVSGGYGGSGO 60
1 GVIEAGAFQGGQRTQTKSGPVILAOEI-KNPAMEKLELVRKWSLNTYKCTRQIISEKIJ:;R 117.. .·.. ... . .. : ::: . ... .. . '" , . .... .. ..
2 GLIPl'GSGIUlPSHSTl'PSGP---GOEVARGIAGEKFDIVKKWGIN'I'YKCTKQLLSERFGR 117
·.... .... . .. ... . .. . .. , ". .. . . . . . . . . . .. ..
2 GSRTVDi£iELQI~~TiHiYS~~ADLSQKSPl 177
1 l.iHEEFGYNAOTQKLLAI<NGE'l'LLGAINFFIASVNTr"vNKTIEDTLMTVKQYESAlUEYI)J 237· It....... . .. .. ....
2 i.omGYNAETQ~VNFFVSsINTi,~Q~~~~;·;"':"';"l 237
1 YRTDLEELNT GPRDAN'l'LPKIEQSQHLFQAHKEKYDKMRNDVSVKLKFT .VLHN( 297·....... ... . . " .·... .. ... . .. ..... .. .. .. . .. .. .. .
2 YRTDLEELSLGPRDAGTRGRLESAQATFQAHROKYEKLRGOVAIKLKFLEENKIKVMHK( 297
1 LVLPHNAIAAYFAGNQKQLE· . . . . . . . . .. . . . .. If.. . . . , .· , ..... ...... . , .
2 LLLFHNAVSAYFAGNQKQL!
Figure 18. Arfaptins 1 and 2 have a conserved BAR domain
The two Arfaptin sequences are overall conserved, expecially from position 118 along all the C-
terminus, from were they are nearly identical. The region boxed in pink indicates the BAR domain.
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Figure 19. The BAR domain is an elongated 'banana-shaped' dimer
The BAR domain is an elongated banana-shaped dimer. Each BAR domain monomer
has a coiled-coil structure of three long kinked a helices, which form a six-helix
bundle CA and C). The curvature of the dimer is partly due to the way the monomers
intersect, and partly due to the kinks in helices 2 and 3. The Kd for dimer formation
is 6 !-1M,which may mean that the protein is in a monomerdirner equilibrium In vivo.
The positively charged loop between helices 2 and 3 at the extreme ends of the
dimer is flexible and poorly ordered; the concave surface of the dimer also has
several positively charged patches CB and D), which suggests that this is the surface
that interacts with the phospholipid membranes. This structure of the BAR domain
would fit a curved membrane with a diameter of 220 A.
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Figure 20. Arfaptin can tubulate membranes in vitro
CA)Electron micrographs of liver liposomes incubated with wild-type Arfaptin
and the indicated mutants, that were designed to change the critical positive
residues that are considered to be important for phospholipid binding. Scale bar,
300 nm. CB)COS7 cells expressing wild-type and mutant Arfaptins, showing a
lack of localization due to an altered ability to localize on membranes. Scale bar,
20 urn. Picture taken from Peter et al Science 04
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the immunofluorescence level (Fig. 22), even if it is not yet possible to relate these
tubules to in-vitro tubulation, which is much more clear under EM analysis.
4.6.2 Arfaptin at the TGN
Nothing is at present known about Arfaptin from the transport point of view, nor is its
localization in the cell known. Here I looked first of all to the localization of Arfaptin
compared to the TGN marker TGN46, and the staining showed a high level of co-
localization, even after nocodazole treatment (Figure 21) since is known that the
absence of micro tubules provoke the scission ofthe Golgi complex in 'ministacks'
that maintain the cis-to-trans orientation, and this gives a better separation between the
cis- and the trans elements (by a still unclarified mechanism). As a negative control I
also performed double-staining of Arfaptin with ER exit sites (ERES) using Sec31
marker, and I observed no colocalization of Arfaptin with these structures (not
shown). The significant data are the TGN localization of Arfaptin with EM
microscopy (Unpublished, De Matteis laboratoryDCBO) Another EM experiment
identified Arfaptin on a tubular compartment and not in the stack (Unpublished, De
Matteis laboratory DCBO).
According to my data, Arfaptin is a TGN -resident protein, and thus it may well
act on Golgi exit sites and/or influence the Golgi-to-PM trafficking of a viral protein
. such as VSVG. To verify this hypothesis, I overexpressed GFP-Arfaptin2 and I looked
at the transport ofVSVG from the Golgi to the PM (Fig 23 - 24). This overexpression
of Arfaptin2 strongly delayed the exit from the Golgi complex ofVSVG, even after
long times (120 min at 32°C; Fig. 24). These data support a regulatory role for
Arfaptin in carrier formation at the TGN.
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Arfaptin TGN46 merge
Nocodazole
Figure 21. Arfaptin2 co-localizes with a TGN marker
Immunofluorescence confocal images in Hela cells showing the co-localization of endogenous Arfaptin
and TGN46 at steady-state, and also in the presence ofnocodazole (as indicated) which fragments the
Golgi complex into ministacks that generally maintain their cis-trans orientation.
')
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GST-PKD Arfaptin2-
FLAG
merge
Figure 22. Arfaptin-decorated tubules
Arfaptin2-FLAG localizes on tubules as shown by white arrows into these confocal sections in HeLa
cells co-transfected with GST-PKD. The Arfaptin2-FLAG decorated tubules do not co-localize with
GST-PKD.
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32°C~-------------------+
T= 40 min T= 60 mm
Figure 23. Arfaptin overexpression blocks VSVG transport to the plasma membrane
Hela cells were transfected with GFP-Arfaptin2 and infected with the VSV virus. A temperature block
protocol was used (see Methods, section 3.7) to follow the transport ofVSVG out of the Golgi
complex. The 20 "C block was performed for 2 h and then several time points were followed during
the release at 32 "C. At 40 and at 60 min, the VSVG appears clearly confmed inside the cells, while
the control cells (untransfected) present VSVG on PM.
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Figure 24. Arfaptin blocks Golgi-to-PM transport
Arfaptin has an inhibitory role on transport to the PM. Histograms of the qualitative classification of
VSVG patterns inside Hela cells overexpressing Arfaptin2, compared to cells overexpressing GFP
alone as the control. The same 20 QC- 32 QCprotocol was used as for Figure 21; see Materials and
Methods, section 3.7.2.
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4.6.3 PKD regulates Arfaptin2
The interaction with PKD appears ~obe affected by phosphatase inhibitors, although
this would not help to distinguish between PKD and Arfaptin, in terms of which one
of the these two interactors is affected. I performed a phosphorylation assay with the
ye2p]- ATP to examine the effects of kinase activity on Arfaptin. In vitro, Arfaptin
appears to be phosphorylated by PKD, suggesting a regulation mediated by the kinase
activity (Fig. 26). Since it has not been possible to verify this kinase activity in vivo
yet, I investigated whether there is a correlation between PKD and Arfaptin, because
they may work on the same trafficking pathway.
First of all, we tried to understand if the Arfaptin pattern on the Golgi complex
can be affected by PKD. Here, I transfected a PKD construct in HeLa cells and I
observed a clear redistribution of endogenous Arfaptin into the cytosol. This effect
was increased when the constitutively active (CA) form of PKD was used (Fig. 27).
This result was not surprising considering-that these two players may work in
different temporal steps in a pathway that starts with Arll: once Arll is active, it
recruits Arfaptin to the Golgi complex to initiate tubulation, with the fissioning protein
PKD involved later, (as demonstrated) by displacing Arfaptin (Fig. 27), making it free
for another cycle oftubulation. Arfaptin can also be recruited by Arfl, but since
Arfaptin is localized specifically at the TGN, we consider that for the TGN-specific
-localization the element that has a role might be an element specifically localized at
TGN, such as Arll.
I next investigated whether GST -PKD-decorated tubules were co-localized
with en_dogenous Arfaptin-decorated tubules, or Arfaptin-FLAG decorated tubules.
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Figure 25. Arfaptin 1 and 2 removal does not affect VSVG exit in Hela cells
The pattern ofVSVG localization after the release from the 20°C block are represented here for PM only, Golgi
only or both Golgi plus PM localization, as indicated during 20 and 40 minutes of release at 32°C. (A) Arfaptinl
knocked down by siRNAs and (B) Arfaptin2 knocked down by siRNAs. The same effect is observed in Arfaptin 1
plus Arfaptin2 siRNAi (not shown). (C) Western blotting of Arfaptinl in (a) siRNA or (b) mock-treted cells and
Western blotting of Arfaptin2 in (c) siRNA or (d) mock-treated cells. Actin is used as a reference.
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Figure 26. PKD phosphoryJates Arfaptin2 in vitro
Autoradiogram showing Arfaptin2 (lane a) with a [32P]-phosphorylaton signal following incubation
with PKD (see Methods, section 3.14.2). (b) Incubation only with the PKD and (C) incubation only in
the presence of Arfaptin, as control. The same conditions were used when PKD was incubated with
BARS (see Figure 17)
113
Arfaptin2 GST-PKDl Merge
Arfaptin2 GST-PKDI-CA Merge
Figure 27. PKD displaces endogenous Arfaptin from the Golgi complex
Hela cells were transfected with wild-type and constitutively active (CA) GST-PKDl. The cells were
fixed after 24 h and stained with an anti-Arfaptin2 antibody and with anti-GST antibody.
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However, the result was negative here, looking at least at three focal planes per cell of
HeLa and Cos7 cells (Fig. 22). This is in line with our model of temporal regulation,
in which Arfaptin and PKD cannot be on the same structure at the same time.
4.7 The TRAPP complex
The TRAPP complex (Yu et al., 2006) component Sedlin interacts with PKD, and
another component, Synbindin, interacts with 14-3-3y. It is also interesting to note the
many genetic interactions that, at least in yeast, link TRAPP to late Golgi trafficking
steps (Fig. 13). Thus a study of the role of TRAPP in post-Golgi trafficking is of
absolute importance. The interaction between Bet3 and Sedlin was expected since it is
known to occur in yeast, and Bet3 and Sedlin are the two most conserved among the
TRAPP subunits (Table 4.6). This interaction was also confirmed in mammals in the
literature a short time after our two-hybrid result (Menon et al., 2006). However
Sedlin is (at least in yeast) sub-stoichiometric in the complex, and after a series of
attempts to study its role in transport, it appeared not to be relevant in trafficking of
VSVG (data not shown). Bet3 instead, once it was knocked-down by siRNA or
acutely depleted after microinjection of its Bet3-specific antibody, blocked the VSVG
travelling from the TGN to the PM. As shown in Figure 29, using a 20°C - 32 °C
transport protocol (see Methods, section 3.7), the VSVG protein reached the Golgi
complex but did not proceed to exocytosis, at least not efficiently. Using the transport
protocol on cells with siRNA interference for Bet3, with a mock as control, I revealed
a strong delay at 30 min, 60 min and also at 90 min after the release at 32°C. This
indicates the important participation of Bet3, which was here knocked down >80%
(Western blotting), and it also indicates participation of the whole TRAPP complex,
because with the knocking down of Bet3, Sedlin and Synbindin also underwent
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Figure 28. VSVG reaches Golgi complex and TGN in Bet3 knocked-down cells
VSVG at the end of the 20°C block reaches the Mannosidasell (Man-II) compartment and the TGN
(TGN46) compartment as shown in confocal sections of HeLa cells interfered for Bet3. This is the
same experiment in which cells were counted for VSVG pattern of transport in Figure 28 A.
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Figure 29. Bet3 removal blocks VSVG exit in Hela cells
The pattern of VSVG localization after the release from the 20 "C block are represented here for PM only, Golgi
only or both Golgi plus PM localization, as indicated during 60 and 90 minutes of release at 32cC. (A) Bet3
knocked down by RNAi (up to 85% by Western blotting as shown in Figure 31) and (B) a Bet3 antibody was
microinjected into the cells during the last 30 min of the 2 h block at 20 "C. A pre-immune IgG was microinjected
as a control. A total of200 cells from three different experiments were counted for (A) and a total of 150 cells
from three different experiments were counted for (B).
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reductions at the protein level (Western blotting; Fig. 30). This would indicate that
Sedlin and Synbindin are probably more exposed to proteolytic degradation in the
absence of the functional TRAPP complex.
I also observed the same effects on acutely blocking Bet3 by microinjecting a
Bet3-specific antibody just before the end of the 20°C block. This defines and
confirms that the defects in transport seen here are not due to an impairment in ER-to-
Golgi transport or to any intra-Golgi step, since under steady state conditions VSVG
proceeded to reach the Golgi/TGN before the microinjection of the Bet3 antibody
(Fig. 29). Ferro-Novick and colleagues (Yu et al., 2006) have claimed a role for Bet3
in ER-to-Golgi trafficking, but they did not use a synchronization protocol to define
the trafficking step they were looking at in their Bet3-depleted cells. Blocking .
antibodies are particularly useful, since we can choose the exact step of transport we
wish to study, as the TGN-to-PM step in this case. Co-localization between VSV-G
and Manll and TGN46 was seen in Bet3 siRNA-treated cells (Fig. 28), since in
chronically depleted cells is not possible to do the temporal restriction made for
microinjection of antibodies, thus it is necessary to observe if the VSV -G can reach
the compartments that came before the TGN and the TGN itself. Then we observed a
clear colocalization between VSVG and TGN46 at time = 0 (Fig. 28), indicating that
previous transport steps are apparently not significantly affected. VSVG is a viral
protein, so its reliability can be questioned for many reasons, and thus we decided to
also follow endogenous cargoes; for this reason, we performed GAG transport assays.
GAGs are constituents of the extracellular matrix and they are sulphated specifically at
the TGN. Thus, by following their esS] incorporation, we can measure their transport
specifically from the TGN to the PM (see Methods, section 3.8).
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The results showed a clear delay inGAG transport out of the Golgi in HeLa
cells siRNA-interfered for Bet3 and also for Sedlin, even if this delay was not so
strong (Fig. 31). Of note, the GAGs are a bulk-flow marker, and can use many
pathways to bypass transport defects and to reach the external surface of the PM
(Buccione et al., 1996; Vuong et al., 2006), and thus it is quite common not to have a
strong delay in any case (Fig. 31).
Thus, looking at VSVG blocked following Bet3 removal in acute and chronic
ways and at GAG sulphation under Bet3 and Sedlin knock-down in a chronic way, we
have demonstrated for the first time that TRAPP is necessary for TGN-to-PM
transport in mammalian cells.
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Figure 30. The knock-down of Bet3 decreases the protein levels of other TRAPP components
Western blotting showing how the levels of Sedlin and Synbindin are also knocked down after Bet3
RNAi for 72 h. The destruction of Bet3 destabilizes the complex and the other TRAPP components
are more prone to proteolitic degradation
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Figure 31. GAG release in Bet3 and Sedlin knock-downs
Individually knocking-down the two subunits of the TRAPP complex, Bet3 and Sedlin in Hela cells,
shows a weak delay in the transport of the GAGs, as compared to the mock control. The experiment was
carried out in triplicate (upper part). The percentage GAG release represents the ratio between the GAG
levels outside ofthe cells and the total GAG (outside plus inside) (see Methods, section 3.8.2). Western
blotting (below) shows knock-down efficiencies for Sedlin and Bet3. Actin is used as a reference.
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5 Discussion
5.1 Overview
What has emerged from every overview of TGN function is the complexity of this
organelle, which is arguably the most complex organelle among the eukaryotic
trafficking stations (De Matteis and Luini, 2008).
Over the past few decades, we have gained some degree of understanding of
the morpho-dynamics of this organelle, and also an awareness that our knowledge of
the underlying molecular machineries is still incomplete and fragmentary. A number
of pieces of a large mosaic have been revealed, but a coherent picture still escapes us.
The ability of cells to export proteins "ina constitutive fashion is basically used
in all cell types (Fig. 5). The membranous carriers involved in the trafficking step
from the TGN directly to the PM are much larger than 'standard' vesicles, and are
pleiomorphic rather than vesicular; they also do not have a proteinaceus coat, as is the
case for many other transport steps (e.g. clathrin, COPI and COPII vesicles)
(Polishchuk et al., 2003).
The first approach of my PhD project was to compile an interaction map of
interesting interactions between the elements known to be part of the (not yet clearly
defined) machineries that work in the TGN-to-PM pathway at different levels. I
collected the protein-protein interactions from databases such as STRING
(http://string.embl.del) and from the literature (Fig. 8)
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I specifically considered tubulating agents such as Arfaptin, lipid-metabolizing
enzymes such as the PI4Ks, and fission proteins such as PKD and BARS. All of these
proteins appear to act in the steps shown in Figure 7, but their roles can be overlapping
between the boundaries of these steps, and our state-of-the-art knowledge about the
boundaries between these machineries is very poor.
For this reason, one of the most important aspects here is the study of the
protein-protein interactions that help to better define the molecular machineries. For
this reason, I set up two-hybrid assays between the chosen proteins, thus allowing me
to enrich the network, as shown in Figure 12. This can also help in our understanding
of which proteins of not yet clear function are a part of the process, thus identifying
new players in TGN-to-PM trafficking, e.g. Arfaptin and the TRAPP complex.
The use of full-length proteins crossed in a two-hybrid interaction matrix, as
carried out in the present work, is much more advantageous, compared to classical
two-hybrid library screening, since the correct folding of proteins is much more likely
to occur when their polypeptide chains are complete, and not in a randomly truncated
form, as in the case of libraries. However, full-length proteins can have regulatory
domains that can mask interaction sites.
Out of 13 newly discovered two-hybrid interactions (Table 4.5) I chose to
specifically confirm three of them: Arfaptin-PKD, Sedlin-PKD and BARS-PKD, with
different approaches, as co-immunoprecipitation for Sedlin-PKD, co-
immunoprecipitation, co-localization and kinase assays for Arfaptin-PKD, and kinase
assays for BARS-PKD!
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Highly connected. protein modules are mostly found to be protein complexes
that often perform specific biological functions. The concept of protein interaction
modules as fundamental functional units was outlined many years ago (Hartwell et al. ,
1999). Protein interaction modules are composed of a variable number of proteins,
with discrete functions that arise from their individual constituents and their
synergistic interactions. A multi-protein complex, such as the ribosome, is one
common form of interaction module; other examples of protein functional modules
include proteins working collectively in a pathway, such as signal transduction
proteins, which do not necessarily form tightly associated, stable protein complexes.
From my analysis, PKD turns out to be an important 'hub' that connects many
elements ofpost-Golgi trafficking (Fig. 12). PKD may act not only in fissioning steps,
as widely described in literature, but also in the regulation of other machineries that
have been implicated in different transport steps, such as Sedlin and Arfaptin, defining
their temporal role in GPC formation.
5.2 BARS is a PKD substrate
PKD and BARS have previously been characterized separately into TGN-to-PM
trafficking, and the new discovered phosphorylation of BARS in vitro opens new
possibility relating to our understanding of the actions and regulation of BARS via
PKD.
BARS acts in dynamin-independent fission events (Bonazzi et al., 2005), and
its better clarified role is in the fission ofVSVG-containing carriers involved in TGN-
to-PM transport. PKD acts on this pathway by specifically blocking basolateral VSVG
transport in MDCK cells when a kinase-dead (KD) mutant is used, and also in COS7
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and HeLa cells (Hausser et al., 2005; Bossard et al., 2007). The PKD-KD mutant is
effective in blocking the fission ofVSVG-containing structures, and acts as a
dominant-negative mutant. This phenotype is very similar to what is observed in
BARS knock-down, or with its nucleotide binding domain (NBD), which is a
dominant-negative domain.
PKD acts on BARS by phosphorylating its NBD domain, which is a dominant-
negative domain in transport from the TGN to the PM, once it is micro injected into
cells (Bonazzi et al., 2005). This indicates that NBD is relevant for fission, and thus
we believe it is not by chance that NBD is the domain of BARS that interacts with
PKD in the two-hybrid system, and that it is the most phosphorylated domain in vitro
compared to other deletion fragments of BARS (Fig. 16). Our hypothesis considers
BARS as a substrate of PKD that drives membrane fission. In the future, the
identification of specific Ser or Thr residues in BARS that can be phosphorylated by
PKD would better clarify the functionality of this interaction.
5.3 PKD regulates Arfaptin activity
Arfaptin is a BAR-domain-cdntaining protein (Peter et al., 2004), and thus it can
tubulate TGN membranes and is an interactor of both Arfl and Arll. Arll is
specifically localized at the TGN(Lu and Hong, 2003; Lu et al., 2006), and Arfl is
known to recruit PI4K to the TGN and to activate it (De Matteis and Godi, 2004).
Even if many elements show that Arfaptin is linked to TON processes, until
now the Arfaptin role has remained completely obscure; thus we wanted to investigate
its role in transport. We have seen here that its overexpression blocks the exit of
VSVG to the PM, even 120 minutes after the release of the 20°C block (Fig. 24). This
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suggests a regulatory role for Arfaptin (Fig. 23 - 24). Separate siRNA silencing of
Arfaptins 1 and 2, and of Arfaptins 1 and 2 together did not produce any relevant
phenotype in transport (Fig. 25), thus indicating that Arfaptin is not strictly necessary
for trafficking and it might be an inhibitory-regulatory component, at least for VSVO
trafficking. We cannot exclude other roles of Arfaptin for other cargoes. The absence
of effect of siRNA on Arfaptin 1,2 could be also due to an incomplete KD, since a
small amount of Arfaptin protein can be sufficient for its function.
Arfaptin localization is TON -specific, as shown by immunofluorescence (Fig.
21), even in the presence ofnocodazole, which forms mini-stacks from the Golgi
complex that maintain their cis to trans orientation.
Even if the formal proof of a role in tubulating of the TON is missing for
Arfaptin, starting from the tubulation activity in vitro (Peter et al., 2004), we
hypothesize that Arfaptin acts in the first step of ope formation, which is a step that
requires membrane-deformation activity.
The action of Arfaptin on TON tubules should occur prior to the action of
PKD, and thus we conclude that they do not work together at the Golgi complex, but
that PKD regulates Arfaptin by 'switching off' its activity, and hence releasing it from
TON membranes, to enter into the system and play its fission role via PI4KIII~D 0
(Hausser et al., 2005) and BARS, cutting off the mature opes. Arfaptin thus may act
on the forming opes in their initial stages of formation.
Looking at the interaction maps in Figure 12, we can conclude that PKD is a
central player that can link this fissioningactivity to other functions, such as
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membrane bending (Arfaptin). Membrane bending precedes the fission events, and
fission can occur in 'hot spots' where the forming ope is narrow (Polishchuk et al.,
2003). At this step, Arfaptin must be removed to let PKD work on those hot spots,
possibly phosphorylating BARS exactly at this fissioning site (Fig. 32). According to
this model, I have demonstrated that endogenous Arfaptin is displaced from the Golgi
complex due to PKD overexpression (Fig. 27), and this makes sense in this context,
considering also that Arfaptin is phosphorylated by PKD (Fig. 26). Arfaptin tubulates
and prepares the forming ope for its removal from the parental membranes, through
its membrane-bending activity, and it is in turn regulated by PKD, which needs to
displace Arfaptin in order to attach to the DAO present at the forming ope, and to
exert its fissioning activity via BARS (Fig. 32). Arfaptin thus has to be removed to
allow a ope to mature, and this can explain the block ofVSVO transport to the
plasma membrane under Arfaptin overexpression (Figs. 23, 24).
Arfaptin in turn can regulate PKD, allowing its fissioning activity to occur only
with well formed intermediates. An unregulated activity of PKD, such as in the case of
a constitutively active form ofPKD (pKD-eA), promotes vesiculation of the TON in
an uncontrolled way (Bossard et al., 2007). Both Arfaptins 1 and 2 can have tubulating
activities, since their BAR domains are conserved (Fig. 18) and they can
heterodimerize, as demonstrated by the two-hybrid interactions between Arfaptins 1
and 2 (Table 4.5).
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Figure 32. A working model
Into this model, Arfaptin promotes the formation of GPCs (a), while PKD acts later (b), when the
GPCs are mature, by phosphorylating Arfaptin, which is thus released from its site of action.
BARS, that is phosphorylated by PKD can then freely fission the transport intermediate (c) at the
sites previously occupied by Arfaptin. PKD thus has a double role, since it first removes Arfaptin,
and then it activate BARS for the fission.
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5.4 TRAPP is involved in the TGN-to-PM trafficking of VSVG
TRAPP has been characterized as a tethering protein complex with a specific role in
ER-to-Golgi trafficking, both in yeast and in mammals. This now appears not to be the
only function of the TRAPP complex since I have here demonstrated for the first time
that it is relevant in VSVG transport from the Golgi complex to the PM, since the KD
ofBet3 strongly impairs TGN-to-PM trafficking ofVSVG. Moreover I have shown
that the ER-to-Golgi trafficking ofVSVG is not affected by interference of TRAPP,
since at the end of a 20 "C block in Bet3 KD cells there was no staining ofVSVG in
the ER and VSVG arrives in Manll and TGN46 compartments (Fig. 28). Also, the
entire TRAPP complex is impaired by knocking-down Bet3, because after siRNA
treatment of Bet3, the protein levels of Sedlin and Synbindin are also decreased, as I
showed by Western blotting (Fig 30).
The new interaction between PKD and Sedlin, together with the new
Synbindin -14-3-3y Ointeraction (see Table 4.5) led me to investigate a role for
TRAPP in TGN-to-PM transport, which was previously suspected because of the role
that TRAPP has in the recycling of Snclp from early endosomesto the Golgi complex
and in the transport of invertase out of the Golgi complex in S. cerevisiae (Cai et al.,
2005).
At present, nothing is known about the function of the Sedlin-PKD interaction,
leaving this to future work for further investigation. Moreover, there are many genetic
interactions between the TRAPP components and Piklp and Ypt31/32, upon which
TRAPPU also has GEF activity (Fig. 12). In mammals, TRAPP is involved in TGN-
to-PM trafficking as I observed here looking at VSVG transport (Fig. 29). This is true
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in chronic Bet3 depletion, and also in acute depletion using Bet3-specific antibodies.
The use of Bet3 antibodies was temporally restricted to the end of 20°C block, to be
sure that the VSVG was accumulated inside the Golgi complex.
Sedlin is part of the TRAPP complex and its interaction with PKDis intriguing
because it provides additional clues to TRAPP participation in post-Golgi events.
Unfortunately, the localization of Sedlin could not be visualized here, and when Sedlin
was overexpressed or knocked-down via siRNA, this did not affect VSVG trafficking
(data not shown) supporting the concept that Sedlin is an accessory/regulatory factor
that might function under an as yet unexplored condition. However, if we want to
study the role of the TRAPP complex, it makes more sense to affect the functioning of
Bet3, since Bet3 is the physical anchor for TRAPP on the membranes (Turnbull et al.,
2005).
In the light of these considerations, it would be interesting to investigate a
possible role of PKD as part of TRAPPII in post-Golgi trafficking, even though
TRAPPII-specific components in mammals are only putative, on an in-silico basis and
with a low homology-score (Cox et al., 2007), and this is not sufficient to definitely
establish its existence in mammals.
Considering this possibility, I would postulate that a role for TRAPP in post-
Golgi transport is provided by additional specific factor(s) that restrict the field of
action of TRAPP to TGN-to-PM transport. This is precisely the case for the yeast
TRAPP complex, when the addition of three subunits (Trs65p, Trs120p, Trs130p)
switches the specificity of GEF activity from Ypt 1p to Ypt31 p, and the mutant of one
of these (Trs130p) blocks invertase inside the Golgi; one of these factors could be
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PKD. PKD is not present in yeast, and this might represent an example of the
evolution of TRAPP functions into higher organisms.
Regulation of TRAPP can be mediated by Sedlin, one of its components.
Sedlin removal has no effect in transport ofVSVG, and its structure is similar to the
longin domain, which is the regulatory N-terminus of some SNAREs e.g. Ykt6 (Jang
et al., 20(2).
The sulphated GAG secretion assay allowed the possibility of looking at an
endogenous soluble cargo. Both Sedlin- and Bet3-siRNA-interfered cells showed a
slight delay in GAG secretion (Fig. 31), indicating a role in TGN-to-PM for an
endogenous cargo that is different from VSVG. GAG molecules are soluble, VSVG is
a membrane protein instead. The small effect of the Bet3 KD in GAG secretion
contrasts with the large inhibition observed for VSVG. This probably indicates a
selective effect on VSVG-containing carriers. The effect of the Sedlin KD that delays
GAG secretion at the same rate as Bet3 KD, contrasts with the absence of effects
observed on the exit ofVSVG (data not shown) during Sedlin KD. This may indicates
a selective effect on GAG-containing carriers.
5.5 Concluding remarks for the future
The aim of my project was the identification of new protein-protein interactions
between proteins that are implicated in TGN-to-PM transport. Moreover, my PhD
project was also focused on the possible discovery of a role in TGN-to-PM for some
proteins that have never been characterized as working in this pathway before, such as
Arfaptin and the TRAPP complex. Arfaptin probably has a regulatory role, since when
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it was overexpressed, it blocked VSVG exit, but since siRNA experiments gave no
relevant phenotype, we are not completely sure about its involvement in TGN-to-PM
trafficking, which could be dependent on other factors; for this reason, Arfaptin might
not be directly involved in TGN-to-PM transport.
The TRAPP complex is necessary for the exit ofVSVG from the Golgi
complex, since siRNA against Bet3 and anti-Bet3 antibodies blocked the exit of
VSVG to the PM. The importance of the Sedlin-PKD interaction is linked to the whole
of the TRAPP complex, because from the 'interactome'point of view (see Figure 12),
the TRAPP complex can be related to late-Golgi trafficking steps, and in yeast, also
functionally (see section 4.4.3). The Bet3 component of the TRAPP complex is a key
element (both in mammals and in yeast), since its depletion destabilizes the complex,
and the other components are then proteolitically degraded (Fig. 30). From the crystal
structure, it is also clear that this central role for Bet3 is important for both membrane
anchoring and catalytic activity as a GEF for Yptlp (Kim et al., 2006; Cai et al.,
2008).
PKD is a part of the same pathway inwhich BARS works; thus the
identification of BARS as a PKD substrate, at least in vitro, is an important finding.
The phosphorylation of BARS needs to be further confirmed in vivo, to clearly
confirm its role downstream ofPKD; moreover, the identification of phosphorylated
residues is necessary, to go deeper into the functionality of this PKD-BARS
interaction.
Considering the many interesting interactions of the several important players
involved inTGN-to-PM transport, another major challenge will be the understanding
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of how the sorting and trafficking processes at the TGN are regulated. For future
work, the study of modular elements, such as PKD, will help experimental design for
the perturbation of more than one element at time, with systematic double siRNA
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